Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Greinix Hildegard |

Presentations at scientific and public conferences

Brunner, A; Mascher, T; Pansy, K.; Gellner, V; Holl, E; Mokry, M; Aigelsreiter, A; Neumeister, P; Greinix, HT; Beham-Schmid, C; Uhl, B; Deutsch, A Distinct expression signatures of chemokine receptors in primary CNS lymphoma.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. memo 15, 37–67 (2022). 2022; -OeGHO- & AHOP-Frühjahrstagung 2022; APR 8-10; Graz, AUSTRIA. [Poster]
FullText

Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, I; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, B; Greinix, HT Autologous stem cell transplantation as rescue therapy for prolonged cytopenia after treatment with CD19-targeted chimeric antigen receptor modifed T-cells: two case reports
Frühjahrstagung 2022 der OeGHO; APR 8-10,2022; Graz. 2022. [Poster]
FullText

Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, IA; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, P; Greinix, HT Autologous stem cell boost for prolonged severe cytopenia after treatment with cd19-car-t-cells for refractory diffuse large b-cell lymphoma -two case reports
BONE MARROW TRANSPL. 2022; 57(SUPPL 1): 141-142. [Poster]
Web of Science FullText

Gaksch, L; Uhl, B; Pansy, K; Schukoff, T; Greinix, HT; Beham-Schmid, C; Neumeister, P; Prochazka, KT; Deutsch, AJ Distinct chemokine receptor expression profles are associated with the clinicopathological features of follicular lymphoma
Frühjahrstagung 2022 der OeGHO; AP 8-10,2022; Graz. 2022. [Poster]
FullText

Garderet, L; Gras, L; Koster, L; D'Souza, A; Estrada-Merly, N; Hari, P; Saber, W; Cowan, AJ; Iida, M; Okamoto, S; Takamatsu, H; Mizuno, S; Kawamura, K; Kodera, Y; Hamad, N; Ko, BS; Liam, C; Ho, KW; Goh, AS; Tan, SK; Elhaddad, AM; Bazarbachi, A; Chaudhry, QUN; Alfar, R; Bekadja, MA; Benakli, M; Ortiz, CAF; Riva, E; Galeano, S; Bass, F; Mian, HS; McCurdy, A; Wang, FR; Neumann, D; Koh, M; Snowden, JA; Schonland, S; McLornan, DP; Hayden, PJ; Sureda, A; Greinix, HT; Aljurf, M; Atsuta, Y; Niederwieser, D Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers
BLOOD. 2022; 140: 4839-4842. Doi: 10.1182/blood-2022-164619
Web of Science FullText FullText_MUG

Garderet, L; Gras, L; Koster, L; D'Souza, A; Estrada-Merly, N; Hari, P; Saber, W; Cowan, AJ; Iida, M; Okamoto, S; Takamatsu, H; Mizuno, S; Kawamura, K; Kodera, Y; Hamad, N; Ko, BS; Liam, C; Ho, KW; Goh, AS; Tan, SK; Elhaddad, AM; Bazarbachi, A; Chaudhry, QUN; Alfar, R; Bekadja, MA; Benakli, M; Ortiz, CAF; Riva, E; Galeano, S; Bass, F; Mian, HS; McCurdy, A; Wang, FR; Neumann, D; Koh, M; Snowden, JA; Schonland, S; McLornan, DP; Hayden, PJ; Sureda, A; Greinix, HT; Aljurf, M; Atsuta, Y; Niederwieser, D International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation
BLOOD. 2022; 140: 5225-5227. Doi: 10.1182/blood-2022-165010
Web of Science FullText FullText_MUG

Garderet, L; Grass, L; Koster, L; D'Souza, A; Estrada, N; Parameswaran, H; Saber, W; Cowan, A; Iida, M; Shin, O; Takamatsu, H; Mitzuno, S; Kawamura, K; Kodera, Y; Hamad, N; Ko, BS; Liam, C; Wah, HK; Goh, AS; Tan, SK; Elhaddad, A; Bazarbachi, A; Chaudhry, Q; Alfar, R; Bekadja, A; Benakli, M; Frutos, C; Riva, E; Galaneo, S; Bass, F; Mian, H; Figueiredo, A; Wang, FR; Neumann, D; Koh, M; Snowden, J; Schoenland, S; Yakoub-Agka, I; Greinix, H; Aljurf, M; Atsuta, Y; Niederwieser, D International differences in baseline characteristics and practice patterns in newly diagnosed multiple myeloma (MM) patients undergoing upfront autologous stem cell transplantation
BONE MARROW TRANSPL. 2022; 57(SUPPL 1):44-45. [Poster]
Web of Science

Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
ÖGR Jahrestagung 2022; NOV 3-5, 2022; Vienna, AUSTRIA. 2022. [Poster]

Langer, R; Lelas, A; Desnica, L; Rittenschober, M; Piekarska, A; Sadowska-Klasa, A; Sabol, I; Greinix, H; Dickinson, A; Inngjerdingen, M; Lawitschka, A; Vrhovac, R; Pulanic, D; Klein, S; Middeke, JM; Grube, M; Holler, E; Edinger, M; Herr, W; Wolff, D Prospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease from multiple transplant centers
BONE MARROW TRANSPL. 2022; 57(SUPPL 1):207-208. [Poster]
Web of Science

Locke, FL; Chou, J; Vardhanabhuti, S; Perbost, R; Dreger, P; Hill, BT; Lee, C; Zinzani, PL; Kroeger, N; Lopez-Guillermo, A; Greinix, H; Zhang, WS; Tiwari, G; To, CA; Cheng, PC; Bot, A; Shen, R; Filosto, S; Galon, J Association of pretreatment (preTx) tumor characteristics and clinical outcomes following second-line (2L) axicabtagene ciloleucel (axi-cel) versus standard of care (SOC) in patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
J CLIN ONCOL. 2022; 40(16): [Oral Communication]
Web of Science

Monch, A; Prochazka, K; Greinix, H; Neumeister, P; Deutsch, A; Uhl, B Specific clinical, serologic, and histopathologic Parameters are associated with inferior Survival of Patients with primary CNS Lymphoma
ONCOL RES TREAT. 2022; 45(SUPPL 2):61-61. [Poster]
Web of Science

Pabst, G; Foßelteder, F; Schlacher, A; Auinger, L; Martinez-Krams, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, Ch; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A; Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells.
Blood (2021) 138 (Supplement 1): 2160.. 2022; 138: 2160-2160.-ASH Annual Meeting 2021; DEZ 11-14, 2021; Atlanta, USA. [Poster]
FullText

Pansy, K,; Fechter, K.; Arra, A; Szmyra, M; Haingartner, S; Ramsay, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A Loss of Nr4a1 is associated with higher expression of immune checkpoint components and reduced T cell-mediated lymphoma cell killing in aggressive lymphoma
HemaSphere 6():p 127-128, June 2022.. 2022; -EHA Research Conference 2022; JUN 9-12, 2022; Vienna. [Oral Communication]
FullText

Pansy, K; Fechter, K; Wenzl, K; Arra, A; Novak, JP; Szmyra, M; Haingartner, S; Ramsay, AG; Novak, AJ; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, AJA Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
BLOOD. 2022; 140: 2038-2039. Doi: 10.1182/blood-2022-163034
Web of Science FullText FullText_MUG

Rudzki, JD; Jaeger, U; Wolf, D; Petzer, A; Greil, R; Peters, C; Greinix, HT; Attarbaschi, A; Buxhofer-Ausch, V; Girschikofsky, M; Holter, W; Leisch, M; Neumeister, P; Schlenke, P; Schmitt, CA; Schwinger, W; Worel, N; Wohlfarth, P Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network
BLOOD. 2022; 140: 6661-6663. Doi: 10.1182/blood-2022-167603
Web of Science FullText FullText_MUG

Szmyra, MM; Haingartner, S; Jantscher, S; Pansy, K; Uhl, B; Greinix, HT; Neumeister, P; Bernhart, E; Beham-Schmid, C; Dengler, MA; Klosch, B; Deutsch, AJA The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax
BLOOD. 2022; 140: 4945-4946. Doi: 10.1182/blood-2022-166678 [Poster]
Web of Science FullText FullText_MUG

Foßelteder, J; Schlacher, A; Pabst, G; Amtmann, B; Schöll, W; Kashofer, K; Beham-Schmid, C; Schlenke, P; Greinix, HT; Sill, H; Woelfler, A; Zebisch, A; Reinisch, A Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN Pathogenesis
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA. Doi: 10.1182/blood-2021-147919 [Poster]
Web of Science FullText FullText_MUG

Gaksch, L; Pansy, K; Schukoff, T; Greinix, H; Beham-Schmid, C; Neumeister, P; Prochazka, K; Deutsch, A Distinct expression profile of chemokine receptors is associated with the pathogenesis of follicular lymphoma
ONCOL RES TREAT. 2021; 44: 152-152. [Poster]
Web of Science

Gaksch, L; Uhl, B; Pansy, K; Schukoff, T; Greinix, H; Beham-Schmid, C; Neumeister, P; Prochazka, K; Deutsch, A Verschiedene Expressionsprofile von Chemokinrezeptoren sind mit der Pathogenese des follikulären Lymphoms assoziiert
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische 2021; OCT 1-4, 2021; Berlin. 2021. [Poster]
FullText

Hatzl, M; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, G; Neumeister, P; Schulz, E BASELINE TOTAL METABOLIC TUMOR VOLUME >220CM³ AND DEAUVILLE 5-POINT SCALE OF ≥4 AFTER FOUR CYCLES OF R-CHOP ARE STRONGLY ASSOCIATED WITH INFERIOR PROGRESSION FREE SURVIVAL IN PATIENTS WITH DLBCL
EHA Library. Hatzl S. 06/09/21; 325281; EP521.. 2021; -26th Congress of the European Hematology Association; JUNE 9-17,2021; virtual . [Poster]
FullText

Pabst, G; Foßelteder, J; Schlacher, A; Auinger, L; Martinez-Krams3, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, C; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA. Doi: 10.1182/blood-2021-149591 [Poster]
Web of Science FullText FullText_MUG

Peric, Z; Schoemans, H; Peczynski, C; Koenecke, C; Moiseev, IS; Basak, GW; Boreland, W; Greinix, HT; Wolff, D; Penack, O Management of Steroid-Refractory Graft-Versus-Host Disease - a Survey By the Transplant Complications Working Party of the EBMT
BLOOD. 2021; 138: Doi: 10.1182/blood-2021-152305 [Oral Communication]
Web of Science FullText FullText_MUG

Pfistershammer, KG; Harrison, N; Graf, A; Trapin, D; Tauber, P; Aberle, JH; Stiasny, K; Schmidt, R; Greinix, H; Ramharter, M; Burgmann, H; Pickl, WF; Bahrs, C The TBE-specific lymphocyte response after HSCT but before vaccination predicts the rapid establishment of humoral immunity after TBE vaccination
EUR J IMMUNOL. 2021; 51: 322-322. [Poster]
Web of Science

Rupp, J; Dreo, B; Gütl, K; Fessler, J; Moser, A; Haditsch, B; Schilcher, G; Greinix, H; Stradner, MH Impaired host antiviral TH1 and CD8 response in highly inflammatory SARS-COV-2 patients
European Congress of Internal Medicine; March 18-20, 2021; virtual congress. 2021. [Oral Communication]

Eglseer, D; Greinix, H Association between malnutrition risk, serum albumin levels and mortality in patients undergoing haematopoietic stem cell transplantation.
Journal of parenteral and enteral nutrition JPEN . 2020; 44(2):259-260.-ASPEN Nutrition Science & Practice Conference ; MAR 28-31, 2020; Tampa, USA. [Poster]
FullText

Lelas, A; Langer, R; Rittenschober, M; Desnica, L; Greinix, H; Dickinson, A; Inngjerdingen, M; Lawitschka, A; Vrhovac, R; Pulanic, D; Klein, S; Middeke, JM; Edinger, M; Wolff, D Incidence of Chronic graft-versus-host Disease - Results from a Prospective Multicentre Analysis of 2 Cohorts.
BONE MARROW TRANSPL. 2020; 55(SUPPL 1):336-337. [Oral Communication]
Web of Science

Rupp, J; Dreo, B; Gütl, K; Fessler, J; Moser, A; Haditsch, B; Schilcher, G; Greinix, H; Stradner, MH Blunted host antiviral T cell response in SARS-CoV-2-induced Cytokine Release Syndrome.
British Society for Immunology virtual conference; DEC 1-2, 2020; virtual. 2020. [Poster]

Sormann, S; Pasteiner, W; Kahangire, DA; Greinix, H Outcomes of relapsed/refractory multiple myeloma patients receiving carfilzomib-based therapy in routine practice; results of a single-centre Austrian registry.
ONCOL RES TREAT. 2020; 43(SUPPL 4):115-115. [Poster]
Web of Science

Toenges, R; Edinger, M; Bug, G; Lawitschka, A; Greinix, H; Halter, J; Arends, J; Ayuk, F; Klein, S; Middeke, JM; Wagner-Drouet, E; Hilgendorf, I; Baumgartner, A; Wolff, D Current Practice in Nutrition after Allogeneic Hematopoietic Stem Cell Transplantation in Austria, Germany and Switzerland.
BONE MARROW TRANSPL. 2020; 55(SUPPL 1):604-605. [Oral Communication]
Web of Science

Bohm, A; Lindner, B; Rabitsch, W; Kalhs, P; Worel, N; Clausen, J; Nachbaur, D; Neumeister, P; Panny, M; Keil, F; Russ, G; Eder, S; Isak, E; Zojer, N; Burger, S; Greinix, H POSTTRANSPLANT OUTCOMES IN ALLOGENEIC AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN AUSTRIA IN COMPARISON TO THE EBMT BENCHMARK: A RETROSPECTIVE ANALYSIS OF THE AUSTRIAN SCT REGISTRY (ASCTR) 2000-2017
TRANSPL INT. 2019; 32: 20-20. [Oral Communication]
Web of Science

Dietrich, S; Finel, H; Lu, JJ; Boumendil, A; Sengeloev, H; Socie, G; Labussiere-wallet, H; Maury, S; Cornelissen, J; Chevallier, P; Colin, M; Greinix, H; Heinicke, T; Kanz, L; Beelen, D; Meijer, E; Schmid, C; Martin, H; Michel, G; Castagna, L; Schmeid, C; Schafer, K; Tsoulkani, A; Bittenbring, J; Finke, J; Koc, Y; Nagler, A; Mohty, M; Robinson, S; Dreger, P; Montoto, S Myeloablative conditioning may contribute to disease control after stem cell transplantation in blastic plasmacytoid dentric cell neoplasia
BONE MARROW TRANSPL. 2019; 54: 108-109.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY. [Oral Communication]
Web of Science

Feichtinger, J; Fechter, K; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA Cytoplasmic NR4A1 in Diffuse Large B Cell Lymphoma
5th International CCS Workshop and 15th International CLL Workshop Salzburg 2019; APR 5-6, 2019; Fuschl am See. 2019. [Poster]

Feichtinger, J; Fechter, K; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA; Cytoplasmic NR4A1 in aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019. [Poster]

Lindahl, C; Unterluggauer, J; Pansy, K; Uhl, B; Prochazka, K; Greinix, H; Weniger, M; Kuppers, R; Beham-Schmid, C; Neumeister, P; Haybaeck, J; Deutsch, A Dysregulated eukaryotic initiation factors may impact on the pathogenesis of primary central nervous system lymphomas
ONCOL RES TREAT. 2019; 42: 82-82. [Poster]
Web of Science

Lindner, B; Greinix, H Ambiguities in data reporting - multiple answer option for causes of death as hinderance for data analysis
BONE MARROW TRANSPL. 2019; 54: 676-677.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY. [Poster]
Web of Science

Pansy, K; Ehall, B; Pursche, B; Greinix, H; Prochazka, K; Beham-Schmid, C; Neumeister, P; Deutsch, A; Fechter, K THE CXCR4-CXCL12 AXIS IS IMPLICATED IN THE BONE MARROW INFILTRATION PROCESS OF DLBCL AND ITS ANTAGONISTS POSSESS PRO-APOPTOTIC EFFECTS IN VITRO
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019. [Poster]

Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas
ONCOL RES TREAT. 2019; 42: 135-135. [Oral Communication]
Web of Science

Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A; Tumor suppressive function of Nr4a1 is mediated by regulation of Pd1-Pdl1-Pdl2 and Ctla4-Cd80-Cd86 axis in aggressive lymphomas
ÖGMBT Annual Meeting; SEP 16-18, 2019; Salzburg, AUSTRIA. 2019. [Oral Communication]

Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck,J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, AJ; Tumor suppressive function of Nr4a1 is mediated by the regulation of immune checkpoints in aggressive lymphomas
ÖGAI Annual Meeting; NOV 21-23; 2019; Graz, AUSTRIA. 2019. [Oral Communication]

Pansy, K; Fechter, K; Wenzl, K; Greinix, H; Prochazka, K; Haybäck, J; Prokesch, A; Feichtinger, J; Neumeister, P; Deutsch, A Nr4a1 is implicated in immune escape by regulating the Pd1-Pdl1-Pdl2 and Ctla4-Cd80-Cd86 axis in aggressive lymphomas
OeGHO- & AHOP-Frühjahrstagung 2019; APR 11-13, 2019; Linz. 2019. [Poster]

Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Greinix, H; Prochazka, K; Beham-Schmid, C; Neumeister, P; Wrodnigg, T; Fechter, K; Deutsch, AJ; Deregulated CXCR4-CXCL12 Signaling Impacts on the Pathogenesis of DLBCL
Lymphoma Biology-Non-Genetic Studies. 2019; -61st ASH Annual Meeting & Exposition; DEZ 7-10, 2019; Orlando, Florida, USA. [Poster]
FullText

Penack, O; Peczynski, C; van der Werf, S; Mohty, M; Yakoub-Agha, I; Montoto, S; Finke, J; Ganser, A; Schoemans, H; Apperley, J; Niittyvuopio, R; Schroyens, W; Unal, A; Gerbitz, A; Schaap, M; Sierra, J; Cortelezzi, A; Wulf, G; Turlure, P; Rovira, M; Ozkurt, Z; Cascon, MP; Clausen, J; Greinix, H; Duarte, R; Basak, G Association of uric acid levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party
BONE MARROW TRANSPL. 2019; 54: 296-297.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY. [Oral Communication]
Web of Science

Penack, O; Peczynski, C; van der Werf, S; Mohty, M; Yakoub-Agha, I; Montoto, S; Finke, J; Ganser, A; Schoemans, H; Apperley, J; Niittyvuopio, R; Schroyens, W; Unal, A; Gerbitz, A; Schaap, M; Sierra, J; Cortelezzi, A; Wulf, G; Turlure, P; Rovira, M; Ozkurt, Z; Cascon, MP; Clausen, J; Greinix, H; Duarte, R; Basak, G Association of serum ferritin levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party
BONE MARROW TRANSPL. 2019; 54: 238-239.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY. [Oral Communication]
Web of Science

Spindelbock, W; Huber-Krassnitzer, B; Uhl, B; Gorkiewicz, G; Greinix, H; Hogenauer, C; Neumeister, P Treatment of acute refractory gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2019; 54: 294-295.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY. [Poster]
Web of Science

Uhl, B; Prochazka, K; Wenzl, K; Beham-Schmid, C; Greinix, HT; Deutsch, AJA; Neumeister, P Substantial differences of the chemokine receptor expression Profile of Richter’s transformed DLBCL compared to de novo diffuse large B-cell lymphoma, transformed follicular lymphoma and GCB-cells.
OeGHO- & AHOP-Frühjahrstagung 2019; ARP 11-13, 2019; Linz, AUSTRIA. 2019. [Poster]

Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83. [Poster]
Web of Science

Bergmann, TC; Pursche, B; Greinix, H; Neumeister, P; Deutsch, A; Prochazka, K Overexpression of miR199a and miR497 regulates Nf-kappa B and B-cell receptor signalling in diffuse large B-cell lymphoma (DLBCL)
ONCOL RES TREAT. 2018; 41: 81-82. [Poster]
Web of Science

Brauchart, T; Bergmann, TC; Pansy, K; Fechter, K; Greinix, H; Neumeister, P; Deutsch, A Starvation increases the anticancer activity of Ibrutinib in ABC-DLBCL cells in vitro
ONCOL RES TREAT. 2018; 41: 81-81.-DGHO; Oktober 2018; wien. [Poster]
Web of Science

Caballero, MD; Cwynarski, K; Dreger, P; Thieblemont, C; Vandenberghe, P; Zinzani, PL; Muller, A; Greinix, H; Avivi, I; Enblad, G; Locke, FL; Yang, Y; Brock, K; Cheng, P; Kersten, MJ ZUMA-7: RANDOMIZED PHASE 3 ESSAY OF AXICABTAGEN CILOLEUCEL (AXI-CEL) VS STANDARD TREATMENT (SOC) IN PATIENTS WITH LYMPHOMA B DIFFUSE OF LARGE CELLS IN RECYCLED/REFRACTORY (R/R DLBCL)
HAEMATOLOGICA. 2018; 103: 359-359.-60th National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy; OCT 11-13, 2018; Granada, SPAIN. [Poster]
Web of Science

Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82. [Poster]
Web of Science

Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83. [Poster]
Web of Science

Fechter, K; Pansy, K; Hauer, A; Kargl, J; Krogsdam, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Prokesch, A; Deutsch, A Nr4a1 has as a tumor suppressive function in Myc-driven lymphomagenesis by altering the tumor microenvironment
ONCOL RES TREAT. 2018; 41: 82-82.-DHGO; Oktober 2018; Wien. [Poster]
Web of Science

Fechter, K; Pansy, K; Hauer, A; Kargl, U; Korgsdam,A; Greinix, H; Beham-Schmid, C; Neumeister, P; Prokesch, A; Deutsch, A Nr4a1 weist eine tumor-suppressive Rolle in der Lymphomenstehung auf und verändert das Mikromilieu der respektiven Tumore"
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28 - OCT 2, 2018; VIENNA, AUSTRIA. 2018. [Poster]

Fechter, K; Pansy, K; Wenzl, K; Prochazka, K;Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
Frühjahrstagung der Österreichischen Gesellschaff für Hämatologie und Medizinische Onkologie ; APR 19-21, 2018; Villach, AUSTRIA. 2018. [Poster]

Greinix, HT; Eikema, DJ; Koster, L; Penack, O; Yakoub-Agha, I; Montoto, S; Chabannon, C; Styczynski, J; Nagler, A; Robin, M; Robinson, S; Chalandon, Y; Mikulska, M; Schonland, S; Peric, Z; Ruggeri, A; Lanza, F; Mohty, M; Basak, GW; Nicolaus, K Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT
BLOOD. 2018; 132: Doi: 10.1182/blood-2018-99-111764
Web of Science FullText FullText_MUG

Meier, S; Kuhl, R; Baurle, M; Wolff, D; Greinix, H; Lawitschka, A; Halter, J; Bertz, H; Hilgendorf, I Exercise therapy for treatment of chronic graft-versus-host disease: recommendations of the German-Austrian-Swiss GvHD consortium
ONCOL RES TREAT. 2018; 41: 64-64. [Oral Communication]
Web of Science

Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81. [Poster]
Web of Science

Pansy,K; Fechter,K ; Greinix, H; Prochazka,K; Neumeister,P; Deutsch,A Loss of Nr4a1 causes up-regulation of Nr4a3 and partially over-expression of p53 in Myc-driven lymphomagenesis
; APR 19-21, 2018; Villach, AUSTRIA. 2018. [Poster]

Schoemans, HM; Goris, K; Van Durm, R; Vanbrabant, K; De Geest, S; Pavletic, SZ; Im, A; Wolff, D; Lee, SJ; Greinix, H; Duarte, RF; Poire, X; Selleslag, D; Lewalle, P; Kerre, T; Graux, C; Baron, F; Maertens, JA; Dobbels, F A National Multi-Center Randomized Study to Assess the Accuracy, Reliability, and User Satisfaction of the Ebmt Gvhd App in Graft Versus Host Disease Assessment
BIOL BLOOD MARROW TR. 2018; 24(3):S191-S191.-Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT); FEB 21-25, 2018; Salt Lake City, UT. Doi: 10.1016/j.bbmt.2017.12.147 [Oral Communication]
Web of Science FullText FullText_MUG

Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50. [Poster]
Web of Science

Sormann, S; Greinix, H Role of TPO agonists in the chronic immune thrombocytopenia treatment algorithm - a single-center registry analysis
ONCOL RES TREAT. 2018; 41: 105-106. [Poster]
Web of Science

Wolff, D; Hilgendorf, I; Wagner-Drouet, EM; Jedlickova, Z; Middeke, JM; Ayuk, FA; Zeiser, R; Lawitschka, A; Halter, J; Klein, SA; Holler, E; Greinix, H Changes in immunosuppressive treatment of chronic graft-versus-host disease - comparison of 2 surveys within hematopoietic stem cell transplant centers in Germany, Austria and Switzerland performed in 2009 and 2018
ONCOL RES TREAT. 2018; 41: 119-119. [Oral Communication]
Web of Science

Aberer, F; Holzgruber, J; Tripolt, NJ; Mader, JK; Pieber, TR; Greinix ,H; Zebisch, A; Woelfler, A; Sourij, H A pilot trial to investigate efficacy and safety of an automized decision support system for the treatment of steroid induced hyperglycemia in patients with acute Graft-versus-host disease
Diabetes.. 2017; 66(S1):A669-A669.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA.

Aberer, F; Holzgruber, J; Tripolt, NJ; Zebisch, A; Greinix, H; Sill, H; Mader, JK; Pieber, TR; Wölfler, A; Sourij, H Efficacy and safety of an insulin decision support system in the treatment of steroid hyperglycaemia in patients with graft-versus- host-disease: a randomised pilot trial.
Diabetologia. 2017; 60(S1):S323-S324.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

Aberer, F; Mader, JK; Stauber, M; Neumeister, P; Oulhaj, Abderrahim; Zebisch, A; Pieber, TR; Greinix, H; Sill, H; Woelfler, A; Sourij, H Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-vs.-Host Disease.
Diabetes.. 2017; 66(S1):A24-A25.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA. [Oral Communication]

Aberer, F; Mader, JK; Stauber, M; Tripolt, N; Holzgruber, J; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, H; Sill, H; Wölfler, A; Sourij, H Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease.
4th International Hospital Diabetes Meeting. 2017; MAY 19-20, 2017; Atlanta, USA. [Poster]

Anne, D; Jean, N; Kralj, JM; Kile, G; Kim, P; Clare, L; Hildegard, G; Rachel, C Expression of serum MicroRNAs is dysregulated during acute graft versus host disease
BONE MARROW TRANSPL. 2017; 52: S486-S486.
Web of Science

Deutsch, A; Pursche, B; Ehall, B; Zoidl, M; Fechter, K; Steinbauer, E; Sedej, M; Greinix, H; Prochazka, K; Wrodnigg, T; Beham-Schmid, C; Neumeister, P; CXCR4 AND CXCL12 ARE IMPLICATED IN BONE MARROW INFILTRATION PROCESS OF AGGRESSIVE B CELL LYMPHOMAS AND THEIR INHIBITION SUPPRESSES LYMPHOMA CELL GROWTH IN VITRO.
HAEMATOLOGICA. HAEMATOLOGICA102: 572-572. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 22nd Congress of the European-Hematology-Association, Madrid, SPAIN, JUN 22-25, 2017)
Web of Science

Ehall, B; Pursche, B; Greinix, H; Prochazka, K; Sedej, M; Zoidl, M; Wroddnigg, T; Neumeister, P; Deutsch, A; Fechter, K; Treatment of lymphoma cell lines with CXCR4 antagonists inhibits cell growth in vitro
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017. [Poster]

Fechter, K;, Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A Loss of Nr4a1 accelerates Myc-driven lymphomagenesis
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017. [Poster]

Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; SEP 29 - OCT 3, 2017 ; Stuttgart, GERMANY. 2017. [Oral Communication]

Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN. [Oral Communication]
Web of Science

Greinix, H Management of steroid-refractory chronic GVHD
43th Annual Meeting of EBMT; Mar 23-29,2017; Marseille, France. 2017. [Keynote lecture]

Greinix,H Chronic graft-versus-host disease
4th WBMT Workshop and Symposium ; Jan 14-18,2017; Riyadh, Saudiarabien. 2017. [Keynote lecture]

Greinix,H Stammzelltransplantation und andere Zelltherapien
Wissenschaftliche Highlights ASH 2016; Jan 26,2017; Graz, AUSTRIA. 2017. [Keynote lecture]

Greinix,H Diagnosis and therapy of GVHD
EBMT Transplantation Complication WP Meeting; Oct 18-21,2017; Granada,Spain. 2017. [Keynote lecture]

Greinix,H Chronic GVHD management
EBMT Training course; Sept 7-9,2017; Barcelona, Spain. 2017. [Keynote lecture]

Greinix,H Assessment and Management of chronic GVHD: Focus on lung, mucosa, eye
ESH-EBMT Training course; May 3-5,2017; Dubin, Ireland. 2017. [Keynote lecture]

Greinix,H GvHD Update
Post-EBMT Symposium; Apr 27,2017; Vienna,AUSTRIA. 2017. [Keynote lecture]

Greinix,H Haploidente Stammzelltransplantation bei AML
Frühjahrstagung der ÖGHO; Apr 6-8,2017; Bregenz, AUSTRIA. 2017. [Keynote lecture]

Hilgendorf, I; Greinix, H; Halter, J; Ayuk, F; Wagner, EM; Lindner, B; Gleich, S; Hochhaus, A; Wolff, D The JETS-project of the German-Austrian-Swiss GVHD Consortium - a prospective study of late effects in adolescent and young adults after stem cell transplantation
ONCOL RES TREAT. 2017; 40: 286-286. [Oral Communication]
Web of Science

Hilgendorf, L; Pulewka, K; Herzberg, PY; Greinix, H; Heussner, P; Mumm, F; von Harsdorf, S; Rieger, K; Hemmati, P; Holler, E; Hochhaus, A; Wolff, D Adolescent and young adults versus older adults in the setting of allogeneic stem cell transplantation - two cohorts with special needs
ONCOL RES TREAT. 2017; 40: 230-231. [Oral Communication]
Web of Science

Jagasia, M; Beohou, E; van der Werf, S; Niederwieser, D; Dreger, P; Meijer, E; Chevallier, P; Sengeloev, H; Blaise, D; Petersen, E; Cornelissen, JJ; Ehninger, G; Gribben, J; Caballero, D; Beguin, Y; Hallek, M; Jindra, P; Fanin, R; Delage, J; Maertens, J; Gedde-Dahl, T; Montoto, S; Kroger, N; Greinix, H; Duarte, R Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses
BONE MARROW TRANSPL. 2017; 52: S83-S83.
Web of Science

Jagasia M; Greinix,HT;Beohou,E; van der Werf,S;Niederwieser, D;Meijer,E; Chevallier,P; Sengeloev,H;Blaise,D;Petersen,E; Cornelissen,JJ; Ehninger,G; Gribben,JG;Caballero,D; Beguin,Y;Hallek,MJ;Jindra,P; Fanin,R; Delage,J; Schoemans,H;Gedde-Dahl,T; Kröger,N; Basak,G; Duarte,RF The Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an Analysis by the EBMT Complications and Quality of Life WP
Blood . 2017; -59th Annual Meeting of the American Society of Hematology; Dec 9-12,2017; Atlanta, USA. [Poster]

Jagasia,M;Greinix,HT; Scheid,C;Socie,G;Ayuk,FA;Tischer,J;Donato,ML;Batai,A; Chin,T; Boodee,HW; Mitri,G A randomized controlled study of extracorporeal photopheresis (ECP) therapy with UVADEX (Methoxaalen) for National Institutes of Health (NIH)-graded moderate to severe chronic graft-vs-host disease (cGVHD)
Blood. 2017; -59th Annual Meeting of the American Society of Hematology; Dec 9-12,2017; Atlanta,USA. [Poster]

Mary, DA; Jean, N; Kralj, JM; Frances, PK; Clare, L; Louis, AB; Matthew, C; Hildegard, G; Emily, CR Serum and extracellular vesicle MicroRNAs miR-423, miR-199 and miR-93*as biomarkers for acute graft-versus-host disease
BONE MARROW TRANSPL. 2017; 52: S509-S509.
Web of Science

Mosieev,IS;Tsvetkova,T; Aljurf,M; Alnounou,RM; Bogardt,J; Chalandon,Y;Drokov,MY; Dvirnyk,V; Faraci,M; Friis,LS;Giglio,F; Greinix,HT;Kornblit,BT; Külper,C; Lewandowski,K; Neumeister,P;Niederwieser,D;Passweg,JR; Penack,O;Peric,Z; Piekarska,A; Ronchi,PE; Rovo,A;Rzepecki,P; Scuderi,F; Sigrist,D;Siitonen,SM; Stoelzel,F; Sulek,K; Tsakiris,DA; Wilkowojska,U; Duarte,RF; Rutuu,T; Basak,GW Evaluation of clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of the Complications and Quality of Life Working Party of the EBMT
Blood. 2017; -59th Annual Meeting of the American Society of Hematology; Dec 9-12,2017; Atlanta, USA. [Poster]

Neumeister, P; Spindelboeck, W; Zinke-Cerwenka, W; Schulz, E; Hoegenauer, C; Sill, H; Gorkiewicz, G; Kump, P; Greinix, H Successful treatment of steroid-refractory acute gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2017; 52: S232-S232.
Web of Science

Panny, M; Prochazka, K; Holzer, K; Neumeister, P; Nosslinger, T; Rathkolb, V; Greinix, H; Keil, F Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis
ONCOL RES TREAT. 2017; 40: 69-70. [Poster]
Web of Science

Pansy, K; Fechter, K; Greinix, H; Prochazka, K; Neumeister, P; Deutsch, A Nr4a1 is implicated in gene regulation in a context specific manner in non-malignant lymphoid tissue
http://www.oegho.at/online-services/veranstaltungen/oegho-fruehjahrstagung-2017/fruehjahrstagung-2017.html. 2017; -OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. [Poster]

Stauber, M; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease
BONE MARROW TRANSPL. 2017; 52: S285-S285.
Web of Science

Uhl, B; Wenzl, K; Fechter, K; Prochazka, KT; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, A; CCR7 expression is associated to favourable cancer specific survival of aggressive lymphoma patients.
OeGHO Frühjahrstagung 2017; APR 6-8, 2017; Bregenz, AUSTRIA. 2017. [Poster]

Aberer, F; Holzgruber, J; Mader, JK; Wölfler, A; Greinix, H; Tripolt, N; Pieber, TR; Sourij, H Pilotstudie zur Überprüfung der Machbarkeit und Effizienz einer normnahen Blutzuckereinstellung mittels eines automatisierten Entscheidungsunterstützungsalgorithmus in der Insulintherapie von Patienten mit Graft-versus-host Erkrankung
Wiener klinische Wochenschrift . 2016; 44(6):410-410.-Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17,19, 2016; Salzburg . [Poster]

Aberer, F; Kremser, S; Zebisch, A; Mader, JK; Sill, H; Greinix, H; Zinke-Cerwenka, W; Pieber, TR; Oulhaj, A; Wölfler, A; Sourij, H Hyperglycemia during the First Month after Allogeneic Hematopoietic Stem Cell Transplantation Is an Independent Risk Factor for Overall Survival in Patients with Acute Myeloid Leukemia.
Diabetes. 2016; 65(S1):A410-A411.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

Aberer, F; Mader, JK; Wolfler, A; Greinix, H; Tripolt, N; Pieber, TR; Sourij, H Pilot Study for Verifying the Feasibility and Efficiency of a standard Blood Glucose Control using an automated Decision Support Algorithm in the Insulin Therapy of Patients with Graft-versus-host Disease
WIEN KLIN WOCHENSCHR. 2016; 128: S407-S407.-44. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

Aberer, F; Stauber, M; Zebisch, A; Greinix, H; Sill, H; Mader, JK; Oulhaj, A; Pieber, TR; Wölfler, A; Sourij, H In-Hospital Hyperglycemia Is Associated with Adverse Outcome in Patients with Acute or Chronic Graft vs. Host Disease after Hematopoeietic Stem Cell Transplantation.
Diabetes. 2016; 65(S1):A390-A390.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

Bainschab, A; Quehenberger, F; Greinix, HT; Krause, R; Wölfler, A; Sill, H; Zebisch, A Antibiotic prophylaxis is associated to a decreased rate of infections in AML patients treated with low-intensity therapeutic regimens
memo - Magazine of European Medical Oncology . 2016; 9(1):20-20.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 17-19, 2016; Vienna, AUSTRIA. [Poster]

Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1
Blood. 2016; -58th Anual Meeting of the American Society of Hematology; Dec 3-6, 2016; San Diego, CA, USA. [Poster]

Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P; NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016) Doi: 10.1182/blood.V128.22.2728.2728
Web of Science FullText FullText_MUG

Greinix, H Zelltherapien bei hämatologischen Erkrankungen
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und medizinische Onkologie; MAR 17-19,2016; Wien. 2016. [Oral Communication]

Greinix, H Pathophysiology of chronic GvHD
GvHD Symposium of the German/Austrian/Swiss Consensus Group on GvHD; APR 29, 2016; Graz. 2016. [Oral Communication]

Greinix, H Cellular biomarkers in chronic GVHD
GvH/GvL Meeting in Regensburg; MAR 15-17,2016; Regensburg. 2016. [Oral Communication]

Greinix, H GVHD
Workshop und Symposium der Arbeitsgruppe für Stammzelltransplantation der ÖGHO; SEPT 16, 2016; Linz. 2016. [Keynote lecture]

Greinix, H Photopherese bei akuter und chronischer GvHD
Transplant Academy der DAG KBT; JUN 23-24, 2016; Berlin. 2016. [Keynote lecture]

Greinix, H Quality measures - How to incorporate Quality into existing and new sites
Annual Meeting of the European Society of Blood and Marrow Transplantation; APR 2-6, 2016; Valencia. 2016. [Keynote lecture]

Greinix, H Sclerodermiform cutaneous GvHD
Annual Meeting of the European Society of Blood and Marrow Transplantation; APR 2-6, 2016; Valencia. 2016. [Keynote lecture]

Greinix, H Management of refractory chronic GvHD
Annual Meeting of the European Society of Blood and Marrow Transplantation; APR 2-6, 2016; Valencia. 2016. [Keynote lecture]

Greinix, H Stammzelltransplantation
15. Onkologische Wintergespräche; JAN 15-16, 2016; Wien. 2016. [Oral Communication]

Greinix, H Non-infectious pulmonary complications
Complications and Quality of Life & Infectious Disease Working Party Joint Educational Course of EBMT; OCT 26-29, 2016; Madrid. 2016. [Keynote lecture]

Greinix, H Zelluläre Immuntherapie
Forum Spital; JUN 16, 2016; Vösendorf. 2016. [Keynote lecture]

Greinix, H Neueste Entwicklungen bei Graft-versus-Host Disease
Wissenschaftliche Gesellschaft der Ärztinnen und Ärzte in der Steiermark; JAN 21, 2016; Graz. 2016. [Keynote lecture]

Greinix, H Pathophysiology of chronic GVHD
3rd International Symposium and Advanced Postgraduate Course in Chronic GVHD; SEPT 19-21, 2016; Zagreb. 2016. [Keynote lecture]

Greinix, H Stammzelltransplantation
Post ASH Winterworkshop Salzburg; JAN 8-9, 2016; Salzburg. 2016. [Oral Communication]

Greinix, H Therapy of GvHD
EBMT Stem Cell Transplant Training Course; SEPT 8-10, 2016; Barcelona. 2016. [Keynote lecture]

Greinix, H Akute myeloische Leukämie und Transplantation
Update Maligne Hämatologie; JUN 18, 2016; Feldkirch. 2016. [Keynote lecture]

Hilgendorf, I; Greinix, H; Halter, J; Ayuk, F; Wagner, EM; Lindner, B; Gleich, S; Hochhaus, A; Wolff, D The JETS-project of the German-Austrian-Swiss GVHD Consortium - a prospective study of late effects in adolescent and young adults after stem cell transplantation
ONCOL RES TREAT. 2016; 39: 286-286. [Oral Communication]
Web of Science

Hilgendorf, I; Pulewka, K; Herzberg, PY; Greinix, H; Heussner, P; Mumm, F; von Harsdorf, S; Rieger, K; Hemmati, P; Holler, E; Hochhaus, A; Wolff, D Adolescent and young adults versus older adults in the setting of allogeneic stem cell transplantation - two cohorts with special needs
ONCOL RES TREAT. 2016; 39: 230-231. [Oral Communication]
Web of Science

Lindner, B; Rumpold, G; Gleich, S; Hilgendorf, I; Halter, J; Lawitschka, A; Ayuk, F; Schoemans, H; Greinix, H; Wolff, D Linking MED-A-data to an external database: the GVHD-registry project
BONE MARROW TRANSPL. 2016; 51: S549-S550.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN. [Poster]
Web of Science

Macher, S; Zinke-Cerwenka, W; Posch, U; Ulrich, S; Sipurzynski, S; Greinix, H; Schlenke, P Thrombozytenrefraktärität durch Anti-HPA 3a bei Zustand nach allogener Blutstammzelltransplantation: ein Fallbericht.
TRANSPL INT. . 2016; 29(s4):21-21.-Austrostransplant 2016; OCT 19-21, 2016; Schladming, AUSTRIA. [Poster]
Web of Science

Panny, M; Troppan, K; Neumeister, P; Nosslinger, T; Holzer, K; Greinix, H; Keil, F TREATMENT OF HIGH RISK AGGRESSIVE B CELL LYMPHOMAS WITH DA EPOCH R- A RETROSPECTIVE ANALYSIS
HAEMATOLOGICA. 2016; 101: 698-698.-21st Congress of the European-Hematology-Association; JUN 09-12, 2016; Copenhagen, DENMARK. [Poster]
Web of Science

Schoemans, HM; Goris, K; Van Durm, R; Vanhoof, J; Greinix, DWPH; Pavletic, SZ; Lee, SJ; Maertens, JA; De Geest, S; Dobbels, F; Duarte, RF The 'EBMT GVHD App' Improves the Accuracy of Graft-Versus-Host-Disease Assessment According to NIH Criteria Compared to Standard Practice
BIOL BLOOD MARROW TR. 2016; 22(3):S284-S284.-BMT Tandem Meetings; FEB 18-22, 2016; Honolulu, HI. Doi: 10.1016/j.bbmt.2015.11.731 [Oral Communication]
Web of Science FullText FullText_MUG

Schwarz, C; Lawitschka, A; Bohmig, G; Dauber, E; Greinix, H; Kozakowski, N; Muhlbacher, F; Berlakovich, G; Wekerle, T Three-Year Outcome After HSCT with Subsequent KT from the Same Haploidentical Donor without Immunosuppression.
AM J TRANSPLANT. 2016; 16: 727-727.-American Transplant Congress; JUN 11-15, 2016; Boston, MA. [Oral Communication]
Web of Science

Stauber, M; Aberer, F; Zebisch, A; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wölfler, A Steroid-induced hyperglycemia adversely impacts outcome in graft-versus-host disease
memo - Magazine of European Medical Oncology . 2016; 9(1):21-21.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 17-19, 2016; Vienna, AUSTRIA. [Poster]

Troppan, K; Beham, C; Greinix, H; Deutsch, A; Neumeister, P; DOUBLE PROTEIN LYMPHOMA PATIENTS OF THE NON-GCB SUBTYPE HAVE AN INFERIOR PROGNOSIS WHEN TREATED WITH CHEMOIMMUNOTHERAPY.
HAEMATOLOGICA. HAEMATOLOGICA101: 396-397. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, JUN 09-12, 2016)
Web of Science

Troppan, K; Pregartner, G; Zach, V; Greinix, H; Neumeister, P Identification of prognostic factors in patients with mature lymphoid malignancies undergoing autologous stem cell transplantation-a single center experience
BONE MARROW TRANSPL. 2016; 51: S506-S506.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN. [Poster]
Web of Science

Worel, N; Fritsch, G; Agis, H; Zojer, N; Ruckser, R; Greinix, H A Higher Amount of More Primitive Stem Cells Is Mobilized By G-CSF Alone Compared to the Addition of Plerixafor: Autologous Blood Stem Cell Graft Composition Collected after Various Mobilization Methods
BIOL BLOOD MARROW TR. 2016; 22(3):S137-S137.-BMT Tandem Meetings; FEB 18-22, 2016; Honolulu, HI. Doi: 10.1016/j.bbmt.2015.11.473 [Poster]
Web of Science FullText FullText_MUG

Worel, N; Lehner, E; Rabitsch, W; Mitterbauer, M; Bauer, W; Schulenburg, A; Hopfinger, G; Just, U; Stary, G; Kalhs, P; Greinix, H Extracorporeal photopheresis in patients with steroid-refractory acute graft-versus-host disease: does the number of UVA-treated leukocytes impact response to therapy?
BONE MARROW TRANSPL. 2016; 51: S375-S376.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN. [Poster]
Web of Science

Aberer, F; Mader, JK; Kremser, S; Zinke-Cerwenka, W; Greinix, H; Pieber, TR; Zebisch, A; Sill, H; Oulhaj, A; Wölfler, A; Sourij, H Glykämie nach allogener Stammzelltransplantation bei Patienten mit akuter myeloischer Leukämie (AML) ist ein unabhängiger Prädiktor für das Überleben.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S135.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

Aberer, F; Stauber, MN; Mader, JK; Greinix, H; Oulhaj, A; Wölfler, A; Sourij, H Assoziation zwischen Hyperglykämie und ungünstigem Outcome bei Patienten mit akuter oder chronischer Graft-versus-Host Erkrankung (GvHD) nach allogener Stammzelltransplantation.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S156-S157.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

Bainschab, A; Quehenberger, F; Greinix, HT; Krause, R; Wolfler, A; Sill, H; Zebisch, A Efficacy of antibiotic prophylaxis in AML patients treated with low-intensity therapeutic regimens
ONCOL RES TREAT. 2015; 38: 73-74. [Poster]
Web of Science

Balsiger, C; Mumm, F; Holler, E; Herzberg, PY; Hilgendorf, I; Hemmati, P; von Harsdorf, S; Greinix, H; Mitchell, SA; Wolff, D; Heussner, P Correlation between somatic comorbidities and anxiety and depression in patients after allogeneic hematopoietic stem cell transplantation
ONCOL RES TREAT. 2015; 38: 148-148. [Oral Communication]
Web of Science

Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
CL LYMPH MYELOM LEUK. 2015; 15: S183-S183. [Oral Communication]
Web of Science

Böhm,A;Rabitsch,W;Greinix,HT;Kalhs,P;Mitterbauer,M;Schulenburg,A;Wöhrer,S;Worel,N;Strunk,D;Linkesch,W;Urban,C;Schwinger,W;Peters,C;Gastl,G;Nachbaur,D;Kircher,B;Clausen,J;Auberger,J;Kriegr,O;Kasparu,H;Hauser,H;Machherndl-Spandl,S;Weltermann,A;Lindner,B Allogeneic stem cell transplantation in patients with acute myeloid leukemia:A report from the Austrian Stem Cell Transplant Registry ASCTR)
Clinical Lymphoma, Myeloma and Leukemia 2015. 2015; 15 (suppl): S183-S183.-Annual Meeting of the Society of Hematologic Oncology; Sept 16-19; Houston. [Oral Communication]

Deutsch, AJA; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Greinix, HT; Beham-Schmid, C; Neumeister, P NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL. [Poster]
Web of Science

Duarte, RF; Boumendil, A; Onida, F; Finel, H; Gabriel, IH; Arcese, W; Browne, P; Beelen, DW; Kobbe, G; Veelken, JH; Arranz, R; Greinix, HT; Lenhoff, S; Poire, X; Ribera, J; Thompson, J; Zuckerman, T; Mufti, GJ; Cortelezzi, A; Olavarria, E; Sureda, A; Dreger, P Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD) - the EBMT Lymphoma Working Party Experience
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA. [Oral Communication]
Web of Science

Gaksch, L; Kashofer, K; Höfler, G; Tinchon, C; Krippl, P; Zebisch, A; Greinix, H; Sill, H; Wölfler, A Feasibility of next generation sequencing for routine diagnostic genetic profiling in myeloid malignancies.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA. [Poster]

Greinix, HT Acute and chronic GVHD: State of the art therapy
ONCOL RES TREAT. 2015; 38: 114-114. [Keynote lecture]
Web of Science

Helene, S; Goris, K; Van Durm, R; Van Hoof, J; Greinix, HT; Wolff, D; Pavletic, SZ; Lee, SJ; Maertens, J; De Geest, S; Dobbels, F; Duarte, RF Development and Preliminary Usability and Accuracy Testing of the EBMT Gvhd App to Support Graft Versus Host Disease Diagnosis and Scoring According to NIH Criteria, By the EBMT Complications and Quality of Life Working Party
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL. [Poster]
Web of Science

Kralj, M; Kuzmina, Z; Weigl, R; Rottal, A; Kormoczi, U; Pick, W; Greinix, H CD19+CD21low B-cells as biomarker for the prediction and monitoring of response to immunosuppressive therapy for chronic graft-versus-host disease
ONCOL RES TREAT. 2015; 38: 127-127. [Poster]
Web of Science

Kremser, S; Aberer, F; Zinke-Cerwenka, W; Neumeister, P; Zebisch, A; Greinix, H; Sill, H; Sourij, H; Wölfler, A Hyperglycemia is an adverse risk factor in AML patients undergoing allogeneic hematopoietic stem cell transplantation.
memo-magazine of european medical oncology; 2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(S1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA. [Poster]

Stauber, M; Aberer, F; Zebisch, A; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A Steroid-induced hyperglycemia adversely impacts outcome in graft-versus-host disease
ONCOL RES TREAT. 2015; 38: 129-129. [Poster]
Web of Science

Troppan K, Wenzl K, Neumeister P, Beham-Schmid C, Przekopowitz M, Greinix H, H Schaider, Deutsch AJA The chemokine receptor profile as distinctive criterion between normal B-cell subsets and as potential discriminative marker to identify the cell of origin in patients with chronic lymphocytic leukemia and Richter syndrome
57th ASH Annual Meeting. 2015; -57th ASH Annual Meeting; DEC 5-8; Orlando, USA. [Poster]

Troppan, K; Wenzl, K; Neumeister, P; Beham-Schmid, C; Przekopowitz, M; Greinix, HT; Schaider, H; Deutsch, AJA The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA. [Poster]
Web of Science

Wenzl, K; Troppan, K; Pursche, B; Bischof, M; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, AJA Loss of NR4A1 Accelerates the Development of Aggressive Lymphomas in Myc Induced Cancerogenesis
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL. [Poster]
Web of Science

Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B Allogeneic Stem Cell Transplantation in patients with acute myeloid leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
ONCOL RES TREAT. 2014; 37: 134-134. [Poster]
Web of Science

Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B; Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION48: S393-S393. LONDON: NATURE PUBLISHING GROUP; ( Presented at: 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013) [Poster]
Web of Science

Lindner, B; Nachbaur, D; Linkesch, W; Krieger, O; Peters, C; Zojer, N; Russ, G; Koller, E; Urban, C; Isak, E; Buxhofer-Ausch, V; Greul, R; Greinix, H on behalf of the Austrian Stem Cell Transplantation Working Group A closer look at registry data: MED-A reporting in Austria in the years 2000 to 2011
Bone Marrow Transplantation. 2013; 48 (suppl 2): S 507-S 507.-39th Annual Meeting of the European Group for Blood and Marrow Transplantation; APR 7-10, 2013; London, UK. [Poster]

Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B Allogeneic stem cell transplantation in patients with acute myeloid leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
European Surgery. 2012; 44(246):16-16.-26. Tagung der Österreichischen Gesellschaft für Transplantation, Transfusion und Genetik; OCT 17-19, 2012; Rust. [Oral Communication]

Krieger, O; Machhemdl-Spandl, S; Hauser, H; Binder, M; Greinix, H; Eder, S; Kahls, P; Rabitsch, W; Nachbaur, D; Ludwig, H; Linkesch, W; Jaeger, G; Sill, H; Lindner, B Stem cell transplantation for MDS patients 1987-2008: data from the Austrian transplant registry (ASCTR)
BONE MARROW TRANSPLANT. 2010; 45: S180-S181. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

Worel, N; Rosskopf, K; Agis, H; Nachbaur, D; Kasparu, H; Russ, G; Keil, F; Linkesch, W; Greinix, H PLERIXAFOR PLUS G-CSF CAN SUCCESSFULLY MOBILIZE CD34+CELLS FROM PATIENTS WHO HAVE PREVIOUSLY FAILED CHEMOTHERAPY AND/OR CYTOKINE MOBILIZATION: THE COMPASSIONATE USE EXPERIENCE IN AUSTRIA
VOX SANG. 2010; 99: 9-10. [Poster]
Web of Science

Worel, N; Rosskopf, K; Nachbaur, D; Kasparu, H; Russ, G; Namberger, K; Leitner, G; Kalhs, P; Schogl, E; Witt, V; Greinix, H; Keil, F; Linkesch, W Plerixafor plus G-CSF can successfully mobilize CD34+cells from patients who have previously failed chemotherapy and/or cytokine mobilization: the compassionate use experience in Austria
BONE MARROW TRANSPLANT. 2010; 45: S318-S318. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

Avivi, I; Canals, C; Niederwieser, D; Kanz, L; Finke, J; Greinix, H; Nagler, A; Vaernant, JP; Bregni, M; Haioun, C; Linkesch, W; Schwerdtfeger, R; Sureda, A Matched unrelated donor stem cell transplantation for patients with diffuse large cell B cell lymphoma: a retrospective analysis of 118 patients registered through the European Group for Blood and Marrow Transplantation (EBMT)
BONE MARROW TRANSPLANT. 2008; 41: S43-S43.-34 th Meeting of the EBMT; MARCH 30- APR 2, 2008; Florence, ITALY. [Keynote lecture]
Web of Science

Avivi, I; Canals, C; Taghipour, G; Niederwieser, D; Kanz, L; Ehninger, G; Finke, J; T.-Greinix, H; Nagler, A; Vernant, JP; Maury, S; Bregni, M; Linkesch, W; Schwerdtfeger, R; Sureda, A Matched Unrelated Donor Stem Cell Transplantation for Patients with Diffuse Large Cell B Cell Lymphoma: A Retrospective Analysis of 118 Patients Registered through the European Group for Blood and Marrow Transplantation (EBMT).
Blood. 108(11):182a-182a.-48 th Annual Meeting of the American Society of Hematology; 12, 2006; Orlando, USA. [Oral Communication]

Langner, S; Staber, PB; Zebisch, A; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Greinix, H; Kalhs, P; Rabitsch, W; Neumeister, P Adding palifermin in allogeneic and autologous stem cell transplantation resulted in reduced oral mucositis and enhanced intestinal mucosal recovery measured by citrulline serum levels.
BLOOD. 2006; 108(11): 404B-404B. Doi: 10.1182/blood.V108.11.5251.5251 [Poster]
Web of Science FullText FullText_MUG

Ludwig, H; Linkesch, W; Kahls, P; Zojer, N; Krieger, O; Greinix, H; Hinterberger, W; Pittermann, E; Bauer, F; Drach, J; Gisslinger, H; Greil, R; Gastl, G;; Results of autologous transplantation for multiple myeloma in Austia. An analysis based on data from the Austrian stem cell registry(ASCT).
The Haematol J. 2004; 5(2):126-126. [Poster]

Ludwig, H; Zojer, N; Linkesch, W; Kahls, P; Krieger, O; Greinix, HT; Hinterberger, W; Pittermann, E; Bauernhofer, T; Gastl, G Results of autologous transplantation for multiple myeloma (MM) in Austria. An analysis based on data from the Austrian Stem Cell Transplantation (ASCT) Registry
J CLIN ONCOL 2004 22: 596S-596S.
Web of Science

Sormann,S; Greinix,H; Loidolt,G; Niederwieser,D; Nachbaur,G; Fridrik,M; Krieger,O; Ludwig,H; Reisner,R; Linkesch,W; Autologous stem cell transplantation for acute myeloid leukaemia in first complete remission in Austria.
Proceedings of the 17th meeting of the Int.Soc of Haematology2003; 61-61.-17th meeting of the Int.Soc of Haematology; SEP 7-10, 2003; Graz,AUSTRIA. [Poster]

Krieger,O; Machherndl-Spandl,S; Greinix,H; Kahls,P; Mitterbauer,M; Rabitsch,W; Nachbaur,D; Niederwieser,D; Gadner,H; Karlhuber,S; Peters,C, Linkesch,W; Jäger,G; Schwinger,W; Pammer,G; Urban,C; Kasparu,H; Lutz,D; Gritsch,B; Stammzelltransplantationen in Österreich bei MDS-Patienten: Retrosp. Auswertung der ASCTR Daten.
Acta Med Aust. 2002; 29: 25-25.- ; ; . [Oral Communication]

Sormann,S; Linkesch,W; Greinix,H; Loidolt,G; Niederwieser,D; Nachbauer,G; Fridrik,M; Krieger,O; Ludwig,H; Reisner,R; Urban,C; Autologous stem cell transplantation for acute myeloid leucemia in complete remission in Austria.
Acta Med Aust. 2002; 29: 19-19.- ; ; . [Oral Communication]

Sormann,S;Linkesch,W; Greinix,H; Loidolt,G; Niederwieser,D; Nachbaur,G; Fridrik,M; Krieger,O; Ludwig,H; Reisner,R; Urban,C; (Austrian Group for Stem Cell Transplantation) Autologous stem cell transplantation for acute myeloid leucemia in complete remission in Austria
Acta Med Austriaca ( suppl 57 ) 2002; 19--Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie ; APR 27,2002; Linz. [Oral Communication]

Greinix, HT; Nachbaur, D; Krieger, O; Eibl, M; Kalhs, P; Lutz, D; Linkesch, W; Niederwieser, D; Rosenmayr, A; Gritsch, B Factors impacting leukemia-free and overall survival of patients with acute myelogenous leukemia after allogeneic stem cell transplantation: report of the Austrian stem cell transplantation registry
BONE MARROW TRANSPLANT. 2001; 27: S81-S81.
Web of Science

Keil, F; Elahi, F; Greinix, HT; Fritsch, G; Louda, N; Petzer, AL; Prinz, E; Wagner, T; Kahls, P; Lechner, K; Geissler, K Expansion of colony forming cells of high proliferation potential and long term culture initiating cells by IL-10, SCF and IL-3 in vitro
Acta Chirurgica Austriaca 2001; 33(178):8-8.-Austrotransplant; ; . [Poster]

Sormann,S; Linkesch,W; Greinix,H; Niederwieser,D; Autologous stem cell transplantation for acute myeloid leukemia in complete remission in Austria.
Onkologie. 2001; 24: 203-203.- ; ; . [Poster]

Greinix,HT; Nachbaur,D; Krieger,O; Eibl,M; Kahls,P; Lutz,D; Linkesch,W; Loidolt,H; Niederwieser,D; Rosenmayr,A; Gritsch,B; Long-term leukemia free survival of patients with acute myelogeneous leukemia after allogeneic stem cell transplantation(SCT): report of the Austrian stem cell registry.
Onkologie. 2000; 32: 4-4.- ; ; . [Poster]

Kahls,P; Greinix,HT; Nachbaur,D; Niederwieser,D; Linkesch,W; Eibl,B; Lechner,K; Rosenmayr,A; Fischer,G; Unrelated donor BMT in adults in Austria: experience in 134 patients.
Acta Chir Aust2000; 32: 19-19.- ; ; . [Keynote lecture]

Kahls,P; Greinix,HT; Nachbaur,D; Niederwieser,D; Linkesch,W; Eibl,B; Lechner,K; Rosenmayr,A; Fischer,G; Unrelated donor BMT in adult patients: experience in 112 patients.
Bone Marrow Transpl. 2000; 25: 89-89.- ; ; . [Keynote lecture]

Kahls,P; Greinix,HT; Nachbaur,D; Niederwieser,D; Linkesch,W; Eibl,M; Lechner,K; Rosenmayr,A; Fischer,G; Unrelated donor BMT in adults in Austria: experience in 134 patients.
Onkologie. 2000; 23: 289-289.- ; ; . [Poster]

Linkesch,W; Sormann,S; Greinix,H; Loidolt,G; Niederwieser,D; Nachbaur,G; Friedrik,M; Krieger,O; Ludwig,H; Reisner,R;Urban,C Autologous bone marrow transplantation for acute myeloid leucemia in CR in Austria. A longterm follow up.
Bone marrow transpl 2000; 25 ( suppl 1): S 82--26th Annual Meeting European Group of Blood and Marrow Transplantation; MÄRZ 6 , 2000; Innsbruck. [Oral Communication]

Ludwig,H; Greinix,HT; Nachbaur,D; Niederwieser,D; Linkesch,W; Lutz,D; Hinterberger,W; Pittermann-Höcker,E; Fridrik,M; Gastl,AG; Schuster,J; High-dose chemotherapy and stem cell transplantation in multiple myeloma: an analysis of the data reported to the Austrian stem cell transplantation registry(ASCTR).
Bone Marrow Transpl. 2000; 25: 325-325.- ; ; . [Poster]

Mitterbauer,W; Brugger; Neumeister,P; Kajls,P; Rabitsch,W; Loidolt,H; Keil,F; Hinterberger,W; Linkesch,W; Mannhalter,C; Mitterbauer,G; Greinix,HT; Clinical and molecular disease eradication after allogeneic stem cell transplantation in patients with advanced non-Hodgkin's lymphoma.
Bone Marrow Transpl. 2000; 25: 42-42.- ; ; . [Poster]

Samonigg,H; Ludwig,H; Hinterberger,W; Lutz,D; Greinix,HT; Nachbaur,D; Niederwieser,D; Gastl,G; Baumgartner,G; Hausmanninger,H; Linkesch,W; Pittermann-Höcker,E; Fridrik,M; Schuster,J; High-dose chemotherapy and stem cell transplantation in patients with breast cancer: an analysis of the data reported to the Austrian stem cell transplantation registry(ASCTR).
Bone Marrow Transpl. 2000; 25: 325-325.- ; ; . [Poster]

Worel,N; Ludwig,H; schuster,J; Fridrik,M; Gastl,G; Hinterberger,W; Höcker,P, Linkesch,W; Lutz,D; Pittermann-Höcker,E; Schönitzer,D; Greinix,HT; Autologous stem cell transplantation in multiple myeloma: analysis of reported to the Austrian stem cell transplantation registry(ASCTR).
Acta Chir Aust. 2000; 32: 28-28.- ; ; . [Keynote lecture]

Worel,N; Ludwig,H; Schuster,J; Fridrik,M; Gastl,G; Hinterberger,W; Höcker,P; Linkesch,W; Lutz,D; Pittermann-Höcker,E; Schönitzer,D; Greinix,HT; Autologous stem cell transplantaion in multiple myeloma: an analysis of data reported to the Austrian stem cell registry(ASCTR).
Onkologie. 2000; 23: 300-300.- ; ; . [Poster]

Eibl,B; Gächter,A; Nachbaur,D; Mitterschiffthaler,A; Urban,C; Greinix,H; Peters.C; Lätzer,K; Niederwieser,D Stellenwert der Limiting Dilution Analyse in der Auswahl von Fremdspendern.
Acta Chir Austriaca 1999; 31 ( suppl 158 ): 7--13. Jahrestagung der Österreichischen Gesellschaft für Transplantation, Transfusion und Genetik (AUSTROTRANSPLANT); OKT 21 , 1999; St. Wolfgang. [Oral Communication]

Krieger,O; Kasparu,H; Greinix,H; Kahls,P; Rabitsch,W; Linkesch,W; Jäger,G; Gadner,H; Peters,C; Schwinger,W; Urban,Ch; Nachbaur,D; Gritsch,B, Niederwieser,D; Lutz,D; Stemcelltransplantation for mDS-patients: Data from the Austrian TX-Registry(ASCTR)
Onkologie1999; 22: 22-22.- ; ; . [Poster]

Mitterbauer, M; Brugger, S; Neumeister, P; Kalhs, P; Rabitsch, W; Loidolt, H; Keil, F; Hinterberger, W; Linkesch, W; Mannhalter, C; Mitterbauer, G; Greinix, H Clinical and molecular disease eradication after allogeneic stem cell transplantation in patients with advanced non-Hodgkin's lymphoma.
BLOOD 1999 94: 4949-4949.
Web of Science

MItterbauer,M; Kahls,P; Brugger,S; Rabitsch,W; Loidolt,H; Keil,F; Hinterberger,W; Neumeister,P; Linkesch,W; Greinix,HT; Allogeneic stem cell transplantation (SCT) in patients with advanced Non-Hodgkin's Lymphoma.
Acta Chir Austriaca1999; 31: 7-7.- ; ; . [Keynote lecture]

Beyer, J; Kramar, A; Mandanas, R; Linkesch, W; Greinix, A; Droz, JP; Pico, JL; Diehl, A; Bokemeyer, C; Schmoll, HJ; Nichols, CR; Einhorn, LH; Siegert, W Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
BONE MARROW TRANSPLANT. 1998; 22: S10-S10.
Web of Science

Greinix, HT; Linkesch, W; Reiter, E; Keil, F; Seifert, M; Czerwenka, K; Elahi, F; Schulenburg, A; Hoecker, P; Kubista, E; Kalhs, P; High dose chemotherapy followed by reinfusion of immunomagnetic purged peripheral blood precursor cells in metastatic and high risk breast cancer patients.
Bone Marrow Transpl1998; 21: 61-61.- ; ; . [Poster]

Greinix, HT; Linkesch, W; Reiter, E; Keil, F; Seifert, M; Czerwenka, K; Elahi, F; Schulenburg, A; Hoecker, P; Kubista, E; Kalhs, P; Vienna, AKH A novel high-dose chemotherapy including paclitaxel with CD34-selected peripheral blood stem cell (PBSC) rescue in high-risk breast cancer patients.
BONE MARROW TRANSPLANT. 1998; 21: S61-S61.
Web of Science

Beyer,J; Kramar,A; Mandanas,R; Linkesch,W; Greinix,a, Droz,JP, Pico,JL; Diehl,A; Bokemeyer,C; Schmoll,HJ, Nichols,CR; Einhorn,LH; Siegert,W; High-dose chemotherapy in germ cell tumors: indentification of progostic factors.
Bone Marrow Transpl1997; 19: 87-87.- ; ; . [Poster]

Beyer,J; Kramar,A; Mandanas,R; Linkesch,W; Greinix,A; Droz,J,P; Pico,J,L; Diehl,A; Bokemeyer,C; Schmolle,H,J; NicholsC,R; Einhorn,L,H, Siegert,W; Optimizing high-dose chemotherapy in germ cell tumors: the application of prognostic factors.
Ann Hamatol1996; 73: A162-A162. [Poster]

Beyer,J; Kramar,A; Mandanas,R; Linkesch,W; Greinix,H.T; Droz,J.p; Pico,J.P; Diehl,A; Bokemeyer,C; Schmoll,C.J; Nichols,C.R; Einhorn,L.H; Siegert,W; High-dose chemotherapy (HDCT) as salvagetreatment in germ cell tumours(GCT): a multivariate analysis of prognostic variables.
J Clin Oncol1996; 15: 239-239.-38th Annual Meeting of ASH; DEC 7-8, 1996; Orlando,FLORIDA. [Keynote lecture]

Brugger,S.A; Kahls,P; Keil,F; Reiter,E; Linkesch,W; Radaszkiewicz,T; Hawlicuek;R; Seifert,M; Jäger,U; Höcker,P; Huber,H; Lechner,K; Greinix,H.T; Haematological and immunological reconstitution after high dose radio and/or chemotherapy with supportive infusion of unselected and CD34+ enriched Peripheral stem cells.
Bone Marrow Transpl1996; 17(1):134-134. [Poster]

Brugger,S.A; Kahls,P; Keil,F; reiter,e; Linkesch,W; Radaszkiewicz,T; Hawliczek,R; Hinterberger,W; Jäger,U; Lechner,K; Greinix,H.T; Bone marrow and peripheral stem cell transplantation for Non-Hodgkin's Lymphoma - Results of the BMT-Centre Vienna.
Bone Marrow Transpl1996; 17: 26-26. [Poster]

Keil,F; Kahls,P; Haas,O.A; Fritsch,G; Mitterbauer,G; Brugger,S; Lechner,K; Schwarzinger,I; Reiter,E; Mannhalter,C; Linkesch,W; Höcker,P; Greinix,H.T; Documentation of hematopoietic chimerism in relapse of BCR/ABL positive CML and all by cell sorting and fluorescent in situ hybridisation can predict aplasia after donor lymphocyte infusion.
Bone Marrow Transpl1996; 17: 85-85. [Poster]

Keil,F; Kahls,P; Haas,O.A; Fritsch,G; Mitterbauer,G; Brugger,S; Lechner,K; Schwarzinger,I; Reiter,E; Mannhalter,C; Linkesch,W; Höcker,P; Greinix,H.T; Graft failure after donor leukocyte infusion in relapsed chronic myeloid leukemia: Successful treatment with cyclophosphamid and antithymocyte globuline followed by peripheral blood stem cell infusion.
Bone Marrow Transpl1996; 17(1):90-90. [Poster]

Reiter,E; Greinix,H.T; Brugger,S; Keil,F; Hinterberger,W; Lechner,K; Linkesch,W; Höcker,P; Haas,O.A; Mannhalter,Ch; Kahls,P; Treatment of CML Relapse after Allogenic Bone Marrow Transplantation.
Bone Marrow Transpl1996; 17(1):90-90. [Poster]

Schmidt,H; Sill,H; Apfelbeck,U; Sormann,S; Neumeister,P; Kurz,M; Höcker,P; Greinix,HT; Linkesch,W; Dexa-beam bei hoch-und niedrigmalignen Non-Hodgkin Lymphomen.
Jahrestagung der Österr Ges f Hämatologie und Onkologie1996; 5-5. [Keynote lecture]

Brugger,S.A; Kahls,P; Keil,F; Reiter,E; Linkesch,W; Radaskiewicz,T; Hawliczek,R; Seifert,M; Jäger,U; Höcker,P; Huber,H; Lechner,K; Greinix,H.T; Hämatologische und immunologische Rekonstitution nach Hochdosis-Chemotherapie mit supportiver Infusion von nichtselektionierten und CD34+ angereicherten peripheren Blutstammzellen.
Acta Chir Austriaca1995; 27: 68-68. [Keynote lecture]

Brugger,S.A; Kahls,P; Keil,F; Reiter,E; Linkesch,W; Radaszkiewicz,T; Hawliczek,R; Hinterberger,W; Höcker,P; Jäger,U; Huber,H; Lechner,K; Greinix,H.T; Allogene und autologe Knochenmarkstransplantation als Therapie fortgeschrittener Non-Hodgkin-Lymphome: Ergebnisse der Universitätsklinik für Innere Medizin.
Acta Chir Austriaca1995; 27: 27-27. [Keynote lecture]

Brugger,S.A; Kahls,P; Keil,F; Reiter,E; Linkesch,W; Radaszkiewicz,T; Hawliczek,R; Hinterberger,W; Jäger,U; Lechner,K; Greinix,H.T; Knochenmarktransplantation bei malignen Lymphomen - Ergebnisse der Universitätsklinik Wien.
Acta Med Aust1995; 22: 36-36.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 1995; Salzburg, AUSTRIA. [Keynote lecture]

Brugger,S.A; Kurz,M; Keil,F; Linkesch,W; Kahls,P; Höcker,P; Greinix,H.T; Peripheral-blood-progenitor-cell-rescue after high dose chemo/radiotherapy as treatment for malignancies.
Bone Marrow Transpl1995; 15: 97-97. [Poster]

Greinix,H.T; Keil,F; Brugger,S; Höcker,P; Elahi,F; Kurz,M; Linkesch,W; Lechner,K; Kahls,P; Transplantation of autologous CD34-positive peripheral blood stem cells after high-dose chemo/radiotherapy for neoplastic disease.
Bone Marrow Transpl1995; 15: 40-40. [Poster]

Greinix,H.T; Linkesch,W; Seifert,M; Kubista,E; Czerwenka,K; Brugger,S.A; Höcker,P; Elahi,F; Keil,F; Sevelda,P; Reiter,E; Kurz,M; Kahls,P; Transfusion CD34 positiver Blutstammzellen nach hochdosierter Chemotherapie nach Taxol, Carboplatin und Cyclophosphamid bei Patientinnen mit Mammakarzinom und hohem Rezidivrisiko.
Acta Chir Austriaca1995; 27: 70-70. [Keynote lecture]

Kahls,P; Brugger,S; Keil,F; Höcker,P; Hawliczek,R; Hinterberger,W; Lechner,K; Linkesch,W; Greinix,H.T; Allogeneic BMT beyond the age of 40 years - experience in 42 patients with hematologic malignancy.
Bone Marrow Transpl1995; 15: 17-17. [Poster]

Kahls,P; Brugger,S.A; Keil,F; Reiter,E; Rosenmayr,A; Kurz,M; Lechner,K; Linkesch,W; Greinix,H.T; Knochenmarktransplantation mit Fremdspendern: Erfahrungen des KMT-Zentrums der Universität Wien.
Acta Chir Austriaca1995; 27: 26-26. [Keynote lecture]

Kahls,P; Keil,F; Brugger,S.A; Höcker,P; Hawliczek,R; Fischer,G; Hinterberger,W; Lechner,K; Linkesch,W; Greinix,H.T; Allogenic bone marrow transplantation for hematologic malignancy in patients aged 40 years and older.
Onkologie1995; 18: 16-16. [Poster]

Kalhs, P; Brugger, S; Keil, F; Hocker, P; Hawliczek, R; Hinterberger, W; Lechner, K; Linkesch, W; Greinix, HT Allogeneic marrow transplantation beyond the age of 40 years in patients with hematological malignancy.
BLOOD. 1995; 86(10): 3791-3791.
Web of Science

Keil, F; Kalhs, F; Haas, O; Fritsch, G; Brugger, S; Schwarzinger, ERI; Mannhalter, C; Linkesch, W; Hocker, P; Lechner, K; Greinix, HT Prolonged aplasia after donor leukocyte infusion in relapsed CML unresponsive to bone marrow infusion: Successful treatment with cyclophosphamide and antithymocyte globulin followed by PBSC.
BLOOD. 1995; 86(10): 3794-3794.
Web of Science

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Lechner,K; Mannhalter,C; Schwarzinger,I; Linkesch,W; Höcker,P; Greinix,H.T; Erfolgreiche Behandlung BCR/ABL positiver ALL und CML im Relaps nach allogener Knochenmarktransplantation durch Spenderleukozyten(DLI) - Nachweis von Chimärismus und molekularbiologischer Remission.
Acta Med Aust1995; 22: 35-35.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 1995; Salzburg, AUSTRIA. [Keynote lecture]

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Reiter,E; Lechner,K; Mannthaler,Ch; Schwarzinger,L; Linkesch,W; Höcker,P; Greinix,H.&T; Monitoring of mixed chimerism and T Cell subsets after donor leukocyte infusions (DLI) for relapse of BCR/ABL positive leukemia.
Onkologie1995; 18: 157-157. [Poster]

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Reiter,E; Lechner,K; Mannthaler,Ch; Schwarzinger,L; Linkesch,W; Höcker,P; Greinix,H.T; Successfull treatment of prolonged aplasia and graft failure after donor leukocyte infusion in Philadelphia chromosome positive chronic myeloid leukemia with cyclophpsphamide and antithymocyteglobuline followed by peripheral blood stem cell rescue.
Onkologie1995; 18: 157-157. [Poster]

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Reiter,E; Schwarzinger,I; Lechner,K; Mannhalter,C; Linkesch,W; Höcker,P; Greinix,H.T; Donor lymphocyte induced aplasia for CML in relapse after sex-mismatch BMT: Recovery of minimal residual donor hematopoiesis in vivo and in long in vivo and in long term bone marrow culture(LTBMC).
Acta Chir Austriaca1995; 27: 38-38. [Keynote lecture]

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Reiter,E; Schwarzinger,I; Lechner,K; Mannhalter,C; Linkesch,W; Höcker,P; Lechner,K; Greinix,H.T; Successful treatment of graft failure after donor leukocyte infusion-induced aplasiain Philadelphia chromosome positive chronic myeloid leukemia with cyclophosphamide and antithymocyteglobuline followed by peripheral allogeneic blood stem cell rescue.
Acta Chir Austriaca1995; 27: 37-37. [Keynote lecture]

Keil,F; Kahls,P; Haas,O; Fritsch,G; Mitterbauer,G; Brugger,S; Linkesch,W; Lechner,K; Mannhalter,C; Greinix,H.T; Stimulation of donor granulopoiesis with G-CSF in relapse of BCR-ABL-positive acute lymphoblastic leukemia (ALL) following allogeneic marrow transplantation.
Bone Marrow Transpl1995; 15: 68-68. [Poster]

Keil,F, Zsuh,H; Kahls,P; Brugger,S; Linkesch,W; Lechner,K; Greinix,H.T; Effect of IL3, SCF, GM-CSF and IL-1b on CFU-C proliferation, cytokine production and structure of the adherent layer in long term bone marrow culture(LTBMC).
Bone Marrow Transpl1995; 15: 39-39. [Poster]

Reiter,E; Keil,F; Brugger,s.A; Kahls,P; Hinterberger,W; Lechner,K; Linkesch,W; Höcker,P; Greinix,H.T; Allogene und syngene Knochenmarkstransplantation bei Patienten mit schwerer aplastischer Anämie - Langzeitergebnisse der Universitätsklinik Wien.
Acta Med Aust1995; 22: 34-34.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 1995; Salzburg, AUSTRIA. [Keynote lecture]

Reiter,E; Keil,F; Brugger,S.A; Kahls,P; Hinterberger,W; Lechner,K, Linkesch,W; Höcker,P, Greinix,H.T; Allogene und synogene Knochenmarkstransplantation bei Patienten mit schwerer aplastischer Anämie - Langzeitergebnisse der Universitätsklinik für Innere Medizin I,Wien.
Acta Chir Austriaca1995; 28: 26-26. [Keynote lecture]

Reiter,E, Keil,F; Brugger,S.A; Kahls,P; Hinterberger,W; Lechner,K; Linkesch,W; Höcker,P; Greinix,H.T; Allogenic and syngenic bone marrow transplantation in patients with severe aplastic anemia - long-term results of the University Hospital of Vienna.
Onkologie1995; 18: 38-38. [Poster]

Reiter,E; Keil,F; Brugger,S.A; Kahls,P; Hinterberger,W; Lechner,K, Linkesch,W; Höcker,P, Haas,O.A; Mannthaler,Ch; Greinix,H.T; Rezidivtherapie nach allogener Knochenmarktransplantation bei Patienten mit chronischer myeloischer Leukämie(CML).
Acta Chir Austriaca1995; 27: 36-36. [Keynote lecture]

Brugger,S; Österreicher,C; Greinix,H; Kahls,P; Linkesch,W; Case report: fulminant candida sepsis with involvement of lung, skin, brain and spleen after allogeneic BMT in a patient with SAA.
Bone Marrow Transpl1994; 179-179.-20th Annual Meeting of EBMT; 1994; [Poster]

Brugger,S.A; Friedl,J; Keil,F; Österreicher,C; Kurz,M; Höcker,P; Linkesch,W; Kahls,P; Greinix,H.T; Erfolgreiche Behandlung der aregeneratorischen Anämie nach ABO-major-inkompatibler KMT durch Plasmaaustausch.
Acta Med Aust1994; 21(1):77-77.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Brugger,S.A; Kurz,M; Keil,F; Greinix,H; Kahls,P; Höcker,P; Linkesch,W; Transplantation mit peripheren Blut-Stammzellen mit oder ohne Knochenmark an der Universität Wien.
Frühjahrstagung, Österr Ges f Hämatologie u Onkologie1994; 8-8. [Keynote lecture]

Brugger,S.A; Kurz,M, Keil,F; Greinix;H.T; Kahls,P; Österreicher,C; Höcker,P; Linkesch,W; Transplantations with peripheral blood-stemcells with or without bone marrow at the UNiversity of Vienna.
Acta Med Aust1994; 21(1):301-301.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Brugger,S.A; Kurz,M; Keil,F; Greinix,H.T; Kahls,P; Österreicher,C; Höcker,P; Linkesch,W; Transplantations with peripheral blood-stemcells with or without bone marrow at the University of Vienna.
Onkologie1994; 17(2):71-71. [Poster]

Brugger,S.A; Kurz,M; Keil,F; Greinix,H.T; Kahls,P; Österreicher,C; Höcker,P; Linkesch,W; Transplantationen mit peripheren Blutstammzellen mit oder ohne Knochenmark an der Universität Wien.
Acta Med Aust1994; 21(3):70-70.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Gaiger,A; Henn,T; Greinix,H; Kahls,P; Keil,F; Hört,E; Kyrle,P; Linkesch,W; Geissler,K; Lechner,K; Lion,T; Early detection of disease progression in CML patients using quantitative BCR-ABL PCR- a useful tool for defining the optimal time for BMT.
Bone Marrow Transpl1994; 148-148.-20th Annual Meeting of EBMT; 1994; [Poster]

GREINIX, HT; KEIL, F; KNAPP, S; BRUGGER, S; KALHS, P; LINKESCH, W; LECHNER, K; JAEGER, U ALLOGENEIC MARROW TRANSPLANTATION FOR ADVANCED-STAGE T(14-18) NON-HODGKINS-LYMPHOMA ELIMINATES PCR DETECTABLE CELLS FROM PERIPHERAL-BLOOD AND BONE-MARROW
BLOOD. 1994; 84(10): A214-A214.
Web of Science

Greinix,H; Kahls,P; Keil,F; Linkesch,W; Brugger,S; Österreicher,C; Knapp,S; jäger,U; Radaszkiewicz,T; Hawliczek,R; Hinterberger,W; Lechner,K; Knochenmarktransplantation bei malignen Lymphomen Ergebnisse der Universitätsklinik Wien.
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 8-8.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

Greinix,H; Keil,F; Kahls,P; Linkesch,W; Brugger,S; Österreicher,C; Knapp,S; Kier,P; Hinterberger,W; Lechner,k; Jäger,U; Allogeneic bone marrow transplantation in Non-Hodgkin lymphomas with t(14;18) translocation
Bone Marrow Transpl1994; 154-154.-20th Annual Meeting of EBMT; 1994; [Poster]

Greinix,H; Zsuh,H; Keil,F; Kahls,P; Linkesch,W; Höcker,P; Kurz,M; Geissler,K; Lechner,K; Stem cell factor erhöht das Wacjstum hämatopoetischer Progenitorzellen nach ex-vivo Mafosfamid - Behandlung des Knochenmarks.
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 3-3.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

Greinix,H.T; Keil,F; Brugger,S; Linkesch,W; Hinterberger,W; Lechner,K; Höcker,P; Hawliczek,R; Kahls,P; Allogene und autologe Knochnemarktransplantation (KMT) bei Patienten mit akuter myeloischer Leukämie(AML) Ergebnisse des KMT-Zentrums der Universitätsklinik Wien 1982-1994.
Acta Med Aust1994; 21(1):36-36.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Greinix,H.T; Keil,F; Höcker,P; Kurz,M, Elahi,F; Brugger,S; Linkesch,W; Knöbl,P; Lechner,K; Kahls,P; Autologe KMT mit Mafosfamid-gepurgtem Knochenmark als Konsolidierungstherapie akuter myeloischer Leukämie.
Acta Med Aust1994; 21(3):4-4.-Jahrestagung der Österreichischen Gesellschaft für Inere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Greinix,H.T; Keil,F; Linkesch,W; Kurz,M; Höcker,P; Brugger,S; Knöbl,P; Lechner,K; Kahls,P; Autologous marrow transplantation using purged marrow in acute myeloid leukemia in first and second remission.
Onkologie1994; 17(2):188-188. [Poster]

Greinix,H.T; Keil,F; Zhu,H; Elahi,F; Brugger,S; Höcker,P; Geissler,K; Linkesch,W; Lechner,K, Kahls,P; Transfusion von CD-34-angereicherten Blutstammzellen nach myeloablativen Chemo-/Radiotherapien.
Acta Med Aust1994; 21(3):68-68.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Kahls,P; Brugger,S; Keil,F; Höcker,P; Hawliczek,R; Hinterberger,W; Lechner,K, Linkesch,W; Greinix,H.T; Allogene KMT bei Patienten über 40 Jahren - ERfahrungen des KMT-Zentrums der Universität Wien.
Acta Med Aust1994; 21(3):8-8.-Jahrestagung der Österreichischen Gesellschaft für Inere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Kahls,P; Greinix,H; Brugger,S; Keil,F; Höcker,P; Lechner,K; Hinterberger,W; Linkesch,W; Allogene Knochenmarktransplantation (KMT) bei Patienten mit AML und CML; Ergebnisse des KMT-Zentrums der Universität Wien 1982-1993.
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 3-3.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

Kahls,P; Greinix,H.T; Schwarzinger,I; Keil,F; Linkesch,W; Lechner,K; Thrombociti thrombocytopenic purpura(TTP)- like syndrome in patients receiving cyclosporine A and methylprednisolone for graft versus host disease (GVGHD) prophylaxis after allogeneic bone marrow transplantation(BMT).
Proceedings of the 25th Congress of the International Society of Hematology1994; 692-692.-25th Congress of the International Society of Hematology; APR 17-21, !994; Cancun,MEXICO. [Poster]

Kahls,P; Keil,F; Brugger,S.T; Linkesch,W; Höcker,P; Hawliczek;R; Rosenmayr,A; Hinterberger,W; Lechner,K; Greinix,H.T; Allogeneic bone marrow transplantation (BMT) at the University of Vienna: Experience in 173 patients.
Onkologie1994; 17(2):280-280. [Poster]

KALHS, P; BRUGGER, S; SCHWARZINGER, I; GREINIX, HT; KEIL, F; KYRLE, PA; KNOBL, P; LINKESCH, W; LECHNER, K SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION
BLOOD. 1994; 84(10): A489-A489.
Web of Science

Keil,F; Greinix,H; Zsuh,H; Linkesch,W; Kahls,P; Brugger,S; Lechner,K; Einfluss von IL3, SCF; GM-CSF und IL-1beta auf die proliferation von Vorläuferzellen, Differenzierung und STruktur der adhärenten Zellschicht in der Knochenmarklangzeitkultur (LTBMC)
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 2-2.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

Keil,F; Greinix,H.T; Zhu,H; Kahls,P; Linkesch,W; Brugger,S; Lechner,K, Einfluss von IL3beta SCF, GM-CSF und IL-1B auf die Proliferation von Vorläuferzellen, Differenzierung und Struktur der adhärenten Zellschicht in der Knochenmark-Langzeitkultur(LTBMC).
Acta Med Aust1994; 21(3):56-56.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Keil,F; Greinix,H.T; Zsuh,H; Brugger,S; Kahls,P; Linkesch,W; Lechner,K; Huber,H; Effect of IL3, SCF, GM-CSF and Il-1beta on CFU-proliferation, cytokine production and structure of the adherent layer in LTBMC.
Bone Marrow Transpl1994; 132-132.-20th Annual Meeting of EBMT; 1994; [Poster]

Keil,F; Greinix,H.T; Zsuh,H; Kahls,P; Brugger,S.T, Linkesch,W; Lechner,K; Effect of IL3, SCF, GM-CSF and IL-1beta on CFU-C proliferation, cytokine production and structure of the adherent layer in LTBMC.
Onkologie1994; 17(2):289-289. [Poster]

Keil,F;Greinix,HT;Kahls,P;Linkesch,W;Brugger,S;Mitterbauer,G;Knöbl,P;Mannhalter,C;Lechner,K Knochenmarktransplantation bei Ph pos. ALL
59. Hämatologisch-onkologischer Diskussionsabend der ÖGHO; JAN 13, 1994; Wien. 1994. [Oral Communication]

Linkesch,W; Greinix,H; Kahls,P; Keil,F; Hinterberger,W; Lechner,K; Höcker,P; 300 Knochenmarktransplantationen an der Universität Wien AKH.
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 3-3.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

Linkesch,W; Greinix,H.T; Kahls,P; Keil,F; Krainer,M; Longterm results of phase I/II trial of Carbo PEC with ABMT in refractory or relapsed NSGCT.
Proceedings of the 2nd International Symposium on High-Dose Chemotherapy and Stem Cell Transplantation in solid Tumors1994; 29-29.-2nd International Symposium on High-Dose Chemotherapy and Stem Cell Transplantation in solid Tumors; 1994; [Poster]

Schürer,G; Keil;F; Brugger,S; Linkesch,W; Greinix,H.T; Kahls,P; Allogene KMT bei multiplem Myelom.
Acta Med Aust1994; 21(3):10-10.-Jahrestagung der Österreichischen Gesellschaft für Inere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

Schürer,G; Keil,F; Brugger,S.T; Linkesch,W; Greinix,H.T; Kahls,P; Allogeneic bone marrow transplantation in multiple myeloma.
Onkologie1994; 17(2):529-529. [Poster]

Gaiger,A; Lion,T; Kahls,P; Greinix,H; Keil,F; Henn,T; Laczika,K; Hinterberger,W; Linkesch,W; Mannhalter,C; Lechner,K; Qualitative and quantitative bcr-abl PCR analyses in patients with chronic myleoic leukemia (CML) following allogeneic and syngeneic bone marrow transplantation.
Proceedings of the 19th meeting of the EBMT1993; 37-37.-19th meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

Gaiger,A; Lion,T; Kahls,P; Henn,T; Greinix,H; Keil,F; Laczika,K; Linkesch,W; Mannhalter,C; Lechner,K; Monitoring of minimal residual disease and early detection of relapse in CML patients following bone marrow transplantation using qualitative and quantitative BCR-ABL PCR analysis.
Proceedings of the 27th Annual Scientific Meeting of the European Society for Clinical Investigation1993; 112-112.-27th Annual Scientific Meeting of the European Society for Clinical Investigation; APR 14-17,1993; Heidelberg,GERMANY. [Poster]

Greinix,H;Keil,F;Linkesch,W;Kahls,P;Scholten,Ch;Kier,P;Hinterberger,W;Lechner,K;Jäger,U Allogene Knochenmarktranspkantation bei NHL-Lymphomen mit t(14;18) Translokation
Wien Klin Wochenschr 1993. 1993; (105):743-743.-Wissenschaftl. Tagung der Gesellschaft der Ärzte; OKT 15, 1993; Wien. [Poster]

Greinix,H.T; Keil,F; Höcker,P; Linkesch,W; Kahls,P; Geissler,K; Lechner,K; Stem Cell Factor erhöht das Wachstum hämatopoetischer Progenitorzellen nach Ex-vivo Mafosfamidbehandlung des Knochenmarks.
Acta Chir Austriaca1993; 25: 12-12. [Keynote lecture]

Greinix,H.T; Keil,F; Linkesch,W; Kahls,P; Scholten,Ch; Kier,P; Hinterberger,W; Lechner,K; Jäger,U; Allogene Knochenmarktransplantation bei Non-Hodgkin Lymphomen mit t(14;18) Translokation.
Acta Chir Austriaca1993; 25: 10-10. [Keynote lecture]

Greinix,H.T; Keil,F; Scholten,Ch; Kahls,P; Linkesch,W; Kier,P; Hinterberger,W; Lechner,K, Jäger,U; Allogeneic bone marrow transplantation in Non-Hodgkin Lymohomas with T(14;18) translocation.
Proceedings of the XIIth meeting of the Int. Society of Haematology (European and African Division)1993; 165-165.-XIIth meeting of the Int. Society of Haematology (European and African Division); AUG 28-SEP 3, 1993; Vienna, AUSTRIA. [Poster]

Greinix,H.T; Keil,F; Scholten,Ch; Kahls,P; Linkesch,W; Kier,P; Hinterberger,W; Lechner,K; Jäger,U; Allogeneic bone marrow transplantation in Non-Hodgkin lymphomas with T(14;18) translocation.
Ann Hematol 1993; 67: A41-A41. [Poster]

Greinix,H.T; Kraupp,M; Linkesch,W; Kahls,P; Keil,F; Aminolevulinic acid dehydrase in evaluation of erythroid regeneration after bone marrow transplantation.
Proceedings of the 19th meeting of the EBMT1993; 119-119.-19th meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

Greinix,H.T; Linkesch,W; Kahls,P; Keil,F; Kapiots,S; Schwarzinger,I; Lechner,K; Beurteilung der hämapoetischen Regeneration nach Knochenmarktransplantation anhand hochfluoreszierender Retikulozyten.
Österr Ges f Hämatologie u Onkologie, Frühjahrstagung1993; 17-17. [Keynote lecture]

Kahls,P; Greinix,H; Brugger,St; Keil,F; Lechner,K; Linkesch,W; Allogene Knochenmarktransplantation bei Patienten mit AML und CML Ergebnisse des KMT-Zentrums der Universität Wien 1882 bis 1993.
Acta Chir Austriaca1993; 25: 9-9. [Keynote lecture]

Kahls,P; Greinix,H.T; Schwarzinger,I; Keil,F; Linkesch,W; Lechner,K; Thromotic-thrombocytopenic purpura(TTP)-like syndrome in patients receiving cyclosporine A and methylprednisolone for graft versus host disease(GVHD) proohylaxis after allogeneic bone marrow transplantation(BMT).
Proceedings of the 25th Congress of the International Society of Hematology1993; 692-692.-25th Congress of the International Society of Hematology; APR 17-21; Cancun, MEXICO. [Poster]

Kahls,P; Greinix,H.T; Schwarzinger,I; Müller,H; Keil,F; Linkesch,W; Lechner,K; Thrombocytic thrombocytopenic purpura (TTP)-like syndrome in patients receiving cyclosporine a and methylprednisolone for graft versus host disease(GVHD) prophylaxis.
Proceedings of the 19th Meeting of the EBMT1993; 17-17.-19th Meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

Kahls,P; Greinix,P.T; Schwarzinger,I; Kyrle,P.A; Keil,F; Müller,H; Linkesch,W; Lechner,K; Thrombotisch thrombozytopenische Purpura (TTP)-artiges Syndrom nach allogener Knochenmarkstransplantation (KMT) bei Gabe von Cyclosporin A plus Methylprednisolon (CSA-MP) als Graft-versus-host-disease (GVHD) Prophylaxe.
Österr Ges f Hämatologie, Frühjahrstagung1993; 16-16. [Keynote lecture]

Keil,F; Greinix,H; Kahls,P; Jäger,U; Scholten,Ch; Linkesch,W; Lechner,K; Allogene Knochenmarkstransplantation (KMT) bei Non Hodgkin Lymphomen (NHL) mit T(14;18) Translokation.
Proceedings of the Frühjahrstagung der Österr. Ges f Hämatologie u Onkologie1993; 6-6.-Frühjahrstagung der Österr. Ges f Hämatologie u Onkologie; 1993; [Keynote lecture]

Keil,F; Greinix,H; Kahls,P; Linkesch,W; Lechner,K; Expansion von myeloischen Vorläuferzellen durch IL-3, SCF und GM-SCF in der Langzeitknochenmarkkultur (LTBMC).
Acta Chir Austriaca1993; 25: 13-13. [Keynote lecture]

Keil,F; Greinix,H.T; Kahls,P; Linkesch,W; Lechner,K; Mannhalter,Ch; Allogene Knochenmarktransplantation bei Philadelphia-positiver ALL im zweiten Rezidiv.
Acta Chir Austriaca1993; 25: 11-11. [Keynote lecture]

Kusec,R; Laczika,K; Purtscher,B; Greinix,H; Kahls,P; Knöbl,P; Linkesch,W; Haas,O; Lechner,K; jäger,U; Monitoring of patients with t(8;21)-positive acute myeloid leukemia using AML 1/ETO RT-PCR.
New Trends in the Treatment of Acute Leukemia1993; 106-106.-ESO Meeting ; 1993; [Poster]

Kusec,R; Laczika,K; Purtscher,B; Greinix,H.T; Kahls,P; Knöbl,P; Linkesch,W; Haas,O; Lechner,K; Jäger,U; Monitoring of patients with t(8;21)-positive acute myeloid leukemia using AML1/ETO RT-PCR.
Ann Hematol 1993; 67: A73-A73. [Poster]

Kusec,R; Laczika,K; Purtscher,B; Greinix,H.T; Kahls,P; Knöbl,P; Linkesch,W; Haas,O; Lechner,K; Jäger,U;, PCR-Nachweis der AML1-ETO Fusions-RNA bei akuter myeloischer Leukämie mit t(8;21)
Wien Klin Wochenschr1993; 105: 741-741. [Keynote lecture]

Kusec,R; Laczika,K; Putscher,B; Greinix,H; Kahls,P; Knöbl,P; Linkesch,W; Haas,O; Lechner,K; Jäger,U; PCR-detection and monitoring of the AML 1/ETO fusion gene in patients with t(8;21)-positive acute myeloid Leukemia.
Proceedings of the XIIth meeting of the Int. Society of Haematology (European and African Division)1993; 495-495.-XIIth meeting of the Int. Society of Haematology (European and African Division); AUG 28-SEP 3, 1993; Vienna, AUSTRIA. [Poster]

Kusec,R;Lazika,K;Purtscher,B;Greinix,H;Kahls,P;Knöbl,P;Linkesch,W;Haas,OLechner,K;Jäger,U; PCR-Nachweis der AML1-ETO Fusions-RNA bei akuter myeloischer Leukämie mit t(8,21 )
Konferenzband der Frühjahrstagung der ÖGHO. 1993; 3-3.-Frühjahrstagung der Osterr. Gesellschaft für Hämatologie und Onkologie; MÄRZ 25-27, 1993; Wien, Austria. [Oral Communication]

Linkesch, W; Greinix, HT; Höcker, P; Krainer, M; Kahls, P; Keil, F; Longterm follow up phase I/II trial of ultra-high carboplatin, VP16, Cyclophosphamide with ABMT in refractory or relapsed NSGCT.
Abstract Book1993; 35-35.-International Consensus Conference on Intensive Chemotherapy plus Hematopoietic stem cell transplantation in malignancies.; Jun 4-6, 1993; Lyon, FRANCE. [Poster]

Linkesch,W; Greinix,H; Kahls,P; Keil,F; Krainer,M; GM-CSF vs.G-CSF nach autologer Knochenmarktransplantation.
Acta Chir Austriaca1993; 25: 12-12. [Keynote lecture]

Linkesch,W; Greinix,H; Krainer,M; Wagner,A; Kahls,P; Höcker,P; Autologe Knochenmarktransplantation bei Hodentumoren - 5 Jahre klinische Erfahrungen.
Österr Ges f Hämatologie u Onkologie, Frühjahrstagung1993; 17-17. [Keynote lecture]

Linkesch,W; Greinix,H.T.; Höcker,P; Krainer,M; Wagner,W; Longterm follow up of phase I/II trial of ultra-high carboplatin, VP16, Cyclophosphamide with ABMT in refractory or relapsed NSGCT.
J Clin Oncol1993; 12: 232-232.-29th Annual Meeting; May 16-19, 1993; Orlando,FLORIDA. [Keynote lecture]

Linkesch,W; Greinix,H.T; Kahls,P; Krainer,M; Höcker,P; Keil,F; Longterm follow up of ultra-high carbolatin, VP 16, cyclophosphamide with ABMT in refractory or relapsed NSGCT.
Ann Hematol 1993; 67: A76-A76. [Poster]

Linkesch,W; Krainer,M; Greinix,H.T; Wagner,A; Höcker,P; Ultrahigh dose carboplatin etoposide, cyclophosphamide with ABMT in relapsed and refractory NSGCT-longterm follow up.
Proceedings of the 19th Meeting of the EBMT1993; 76-76.-19th Meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

Österreicher,Ch; Brugger,St; Greinix,H; Kahls,p, Linkesch,W; Fulminante Candidasepsis mit Hautinfiltraten im Rahmen einer allogenen Knochenmarktransplantation-aplastische Anämie-Kasuistik.
Acta Chir Austriaca1993; 25: 12-12. [Keynote lecture]

Scholten,Ch; Greinix,H; Höcker,P; Keil,F; Geissler,K; Laczika,K; Purtscher,B; Linkesch,W; Lechner,K; Jäger,U; Klon-spezifische CDRIII-PCR zum Monitoring von B-Zell Lymphomen/Leukämien.
Proceedings of the Frühjahrstagung der Österr. Ges f Hämatologie u Onkologie1993; 4-4.-Frühjahrstagung der Österr. Ges f Hämatologie u Onkologie; 1993; [Keynote lecture]

Scholten,Ch; Greinix,H; Höcker,P; Keil,F; Geissler,K; Laczika,K; Purtscher,B; Linkesch,W; Mitterbauer,G; Klonspezifische CDR III PCR zum Monitoring von B-Zell-Lymphomen/Leukämien.
Acta Med Aust1993; 20: 72-72.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1993; Salzburg,AUSTRIA. [Keynote lecture]

Scholten,Ch;Greinix,H;Höcker,P;Keil,F;Geissler,K;Lazika,K;Purtscher,B;Linkesch,W;Lechner,K;Jäger,U Klon-spezifische CDRIII-PCR zum Monitoring von B-Zell Lymphomen/Leukämien
Konferenzband der Frühjahrstagung der ÖGHO. 1993; 4-4.-Frühjahrstagung der Osterr. Gesellschaft für Hämatologie und Onkologie; MÄRZ 25-27, 1993; Wien, Austria. [Oral Communication]

Zhu,H; Greinix,H.T; Kurz,M; Höcker,P; Keil,F; Linkesch,W; Ex-vivo-Expansion peripherer Stammzellen.
Acta Chir Austriaca1993; 25: 13-13. [Keynote lecture]

Linkesch, W; Greinix, H; Kahls, P; Keil, F; Hinterberger, W; Lechner, K; Höcker, P 300 Knochenmarktransplantationen an der Universität Wien-AKH
Symposium Knochenmarktransplantation; OKT 28, 1992; Wien, Austria. 1992. [Keynote lecture]

LEHNERT, M; JUTTNER, F; PETRITSCH, PH; SEEWANN, HL; GREINIX, H CISPLATIN BASED SEQUENTIAL CHEMOTHERAPY IN FAR ADVANCED NONSEMINOMATOUS TESTICULAR CANCER (NSTC)
BLUT. 1987; 55(4): 275-275.
Web of Science

SEEWANN, HL; GREINIX, H; URBAN, C TREATMENT OF APLASTIC-ANEMIA WITH CYCLOSPORINE-A
BLUT. 1987; 55(4): 305-305.
Web of Science

Urban,C; Slavc,I; Kaulfersch,W; Greinix,H; Höcker,P Neuroblastom IV: Behandlung mit hochdosiertem Melphalan (HDM) und autologem ASTA-Z-tumorzellsepariertem Knochenmark.
Wien Med Wschr 1987; 16: 371--Wissenschaftliche Sitzung der Gesellschaft der Ärzte in der Steiermark ; JAN 23,1986; Graz. [Oral Communication]

Greinix,H;Urban,C;Slavc,I;Kaulfersch,W;Höcker,P Neuroblastom IV: Behandlung mit hochdosiertem Melphalan(HDM) und autologem ASTA-Z-tumorzellsepariertem Knochenmark.
Kongressband 1985; -23. Jahrestagung der Österr. Ges. f. Kinderheilkunde ; OKT 1985; Eisenstadt. [Oral Communication]

URBAN, C; SLAVC, I; KAULFERSCH, W; GREINIX, H; HOCKER, P TREATMENT OF NEURO-BLASTOMA, STAGE-IV WITH HIGH-DOSE MELPHALAN (HDM) FOLLOWED BY TRANSPLANTATION OF ASTA-Z CHEMOPURIFIED AUTOLOGOUS BONE-MARROW
BLUT. 1985; 51(3): 224-224. [Oral Communication]
Web of Science

↑ Top of page / Navigation